Electroconvulsive and Neuromodulation Therapies


Electroconvulsive and Neuromodulation Therapies

Electroconvlusive therapy (ECT) is a psychiatric treatment involving the induction of a seizure through the transmission of electricity into the brain. In the early eighties, ECT was replaced by far more effective psychopharmacologic medications as a primary treatment modality. Much of the decline in use of ECT at that time was also ascribable to the number of complications associated with the technique. Because of recent refinements and a far better understanding of the scientific mechanisms underpinning ECT, this treatment modality has lately seen a resurgence in use in clinical practice. This book is the new definitive reference on electroconvulsive and neuromodulation therapy. It comprehensively covers both the scientific basis and clinical practice of ECT, as well as providing readers with administrative perspectives for the training and management of this modality in clinical practice. The newer forms of non-convulsive electrical and magnetic brain stimulation therapy are also covered in detail and presented as a separate section.


 Reviews:

"This is an outstanding and uniquely comprehensive book on the important treatment modalities of electroconvulsive and neuromodulation therapies. Electroconvulsive therapy (ECT), even after all these decades of use, and in spite of the "psychopharmacologic revolution," has remained the most effective treatment in psychiatry and is highly effective, safe, and even a life-saving treatment for patients suffering from persistent and severe depression, bipolar disorder, and schizophrenia. Written and edited by internationally recognized clinician-researchers, this book is a needed and welcome addition to the field."
--Doody's Review Service

'It will serve as the benchmark for books covering these important treatment modalities and should be required reading for any clinicians who treat patients with severe psychiatric disorders.' Doody's

'… an important achievement … There is nothing like it anywhere on the subject. It should be on the bookshelf of anyone practising or intending to practise ECT … will contribute worldwide to the understanding and advancement of ECT and other neurotherapeutic modalities.' The American Journal of Psychiatry

Ücok, A. and Cakir, S. 2006. Electroconvulsive therapy in first-episode schizophrenia. J ECT 22: 38–42.
(As laws and regulations are frequently being updated, I believe that the Web sites with the most up-to-date regulations are more appropriate than the specific volume used for these procedures).
Aden v. Younger, 129 Cal. Rptr. 535 (Cal. Ct. App., 1976).
Aiken v. Clary, 396 S.W. 2d 668 (Mo., 1965).
Barclay v. Campbell, 704 S.W. 2d 8 (Tex. Sup. Ct., 1986).
Wyatt v. Hardin. U.S. Dist. (M.D. Ala., 1975).
Abelson, J. L., Curtis, G. C., Sagher, O., et al. 2005. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry 57(5): 510–16.
Abou-Saleh, M. T. and Coppen, A. J. 1988. Continuation therapy with antidepressants after electroconvulsive therapy. Convuls Ther 4: 263–8.
About use of electroshock for treatment of psychical diseases. 1952. [In Russian.] Zh Nevrol Psikhiatr Im S S Korsakova 52(8): 71–3.
Abraham, G., Milev, R., Delva, N., and Zaheer, J. 2006. Clinical outcome and memory function with maintenance electroconvulsive therapy: A retrospective study. J ECT 22(1): 43–5.
Abraham, K. R. and Kulhara, P. 1987. The efficacy of electroconvulsive therapy in the treatment of schizophrenia. A comparative study. Br J Psychiatry 151: 152–7.
Abrams, R. 1991. Seizure generalization and the efficacy of unilateral electroconvulsive therapy. Convuls Ther 7: 213–17.
Abrams, R. 1997. Electroconvulsive therapy, 3rd edn. New York: Oxford University Press.
Abrams, R. 2000. Use of ECT in Italy. Am J Psychiatry 157: 840.
Abrams, R. 2002. Electroconvulsive therapy, 4th edn. New York: Oxford University Press.
Abrams, R. 2002. Electroconvulsive therapy, 4th edn. New York: Oxford University Press.
Abrams, R. 2002. Electroconvulsive therapy, 4th edn. New York: Oxford University Press.
Abrams, R. 2002. Electroconvulsive therapy, 4th edn. Oxford, UK: Oxford University Press.
Abrams, R. 2002. Electroconvulsive therapy, 4th edn. Oxford: Oxford University Press.
Abrams, R. 2002. Electroconvulsive therapy. Oxford: Oxford University Press.
Abrams, R. 2002. Stimulus titration and ECT dosing. J ECT 18: 3–9.
Abrams, R. and Swartz, C. M. 1985. ECT and prolactin release: Relation to treatment response in melancholia. Convulsive Ther 1: 38–42.
Abrams, R. and Taylor, M. A. 1973. Anterior bifrontal ECT: A clinical trial. Br J Psychiatry 122: 587–90.
Abrams, R. and Taylor, M. A. 1973. Anterior bifrontal ECT: A clinical trial. Br J Psychiatry 122: 587–90.
Abrams, R. and Taylor, M. A. 1976. Catatonia: A prospective clinical study. Arch Gen Psychiatry 33: 579–81.
Abrams, R., Dornbush, R. L., Feldstein, S., et al. 1972. Unilateral and bilateral electroconvulsive therapy: Effects of on depression, memory, and the electroencephalogram. Arch Gen Psychiatry 27(1): 88–91.
Abrams, R., Swartz, C. M., and Vedak, C. 1991. Antidepressant effects of high-dose right unilateral electroconvulsive therapy. Arch Gen Psychiatry 48: 746–8.
Abrams, R., Swartz, C. M., and Vedak, C. 1991. Antidepressant effects of high-dose right unilateral electroconvulsive therapy. Arch Gen Psychiatry 48: 746–8.
Abrams, R., Swartz, C. M., and Vedak, C. 1991. Antidepressant effects of high-dose right unilateral electroconvulsive therapy. Arch Gen Psychiatry 48: 746–8.
Abrams, R., Swartz, C. M., Vedak, C. 1991. Antidepressant effects of high-dose right unilateral ECT. Arch Gen Psychiatry 48: 746–8.
Abse, W. 1944. Theory of the rationale of convulsion therapy. Br J Med Psychol 20: 33–50.
Accornero, F. 1988. An eyewitness account of the discovery of electroshock. Convuls Ther 4: 40–9.
Accreditation Council for Graduate Medical Education (ACGME). 2007. ACGME program requirements for graduate medical education in psychiatry, July, 2007. Available at http://www.acgme.org, and present requirements are at http://www.acgme.org/acWebsite/downloads/RRC_progReq/400pr07012007.pdf (accessed September 25, 2008).
Ackner, B., Harris, A., and Oldham, A. J. 1957. Insulin treatment of schizophrenia. Lancet i: 607–11.
Agarwal, A. and Vinny, G. C. 1985. Role of ECT-phenothiazines combination in schizophrenia. Indian J Psychiatry 27: 233–6.
Agarwal, A. K., Andrade, C., and Reddy, M. V. 1992. The practice of ECT in India. I. Indian J Psychiatry 34: 28–97.
Agarwal, A. K., Andrade, C., and Reddy, M. V. 1993. The practice of ECT in India. II. Indian J Psychiatry 35: 81–6.
Agence Nationale d'Accréditation et d'Évaluation en Santé (ANAES). 1997. Indications et modalités de l'electroconvulsivitherapie: Recommendations professionelles. Paris: ANAES.
Ahn, Y. M., Kang, U. G., Oh, S. W., et al. 2002. Region-specific phosphorylation of ATF-2, Elk-1 and c-Jun in rat hippocampus and cerebellum after electroconvulsive shock. Neurosci Lett 329: 9–12.
Aihara, M., Ida, I., Yuuki, N., et al. 2007. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Res 155: 245–56.
Alarcón, R. D. 1993. Perspectivas de la investigación psiquiátrica en América Latina. Acta Psiq Psicol Am Latina 39: 19–31.
Alarcón, R. D. 2003. Mental health and mental health care in Latin America. World Psychiatry 2(1): 54–6.
Albin, S. M., Stevens, S. R., and Rasmussen, K. G. 2007. Blood pressure before and after ECT in hypertensive and non-hypertensive patients. J ECT 23(1): 9–10.
Almeida Filho, N. and Canino, G. 1995. Epidemiología psiquiátrica. In Enciclopedia Iberoamericana de psiquiatría. Vol. 2. (eds. Vidal, G., Alarcón, R. D., and Lolas, F.). Buenos Aires: Editorial Médica Panamericana, pp. 487–501.
Alonso, P., Pujol, J., Cardoner, N., et al. 2001. Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: A double-blind, placebo-controlled study. Am J Psychiatry 158: 1143–5.
Altar, C. A., Laeng, P., Jurata, L. W., et al. 2004. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 24: 2667–77.
Altman, J. and Das, G. D. 1965. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 24(3): 319–35.
American Academy of Child and Adolescent Psychiatry. 2004. Practice parameter for use of electroconvulsive therapy with adolescents. J Am Acad Child Adolesc Psychiatry 43: 1521–39.
American College of Cardiology/American Heart Association (ACC/AHA). 2007. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 50(17): 1707–32.
American Psychiatric Association (APA) Committee on Electroconvulsive Therapy. 2001. The practice of electroconvulsive therapy: Recommendations for treatment, training and privileging, 2nd edn. Washington, DC: APA.
American Psychiatric Association (APA) Committee on Electroconvulsive Therapy. 2001. The practice of electroconvulsive therapy: Recommendations for treatment, training, and privileging Washington, DC: APA.
American Psychiatric Association (APA) Task Force on Electroconvulsive Therapy. 1978. Electroconvulsive therapy. Washington, DC: APA.
American Psychiatric Association (APA). 1978. Electroconvulsive therapy, Task Force Report 14. Washington, DC: APA.
American Psychiatric Association (APA). 1978. Report of the task force on electroconvulsive therapy. Washington, DC: APA.
American Psychiatric Association (APA). 1990. The practice of electroconvulsive therapy: Recommendations for treatment, training, and privileging. Washington, DC: APA Press.
American Psychiatric Association (APA). 1990. The practice of electroconvulsive therapy: Recommendations for treatment, training, and privileging: A task force report. Washington, DC: APA.
American Psychiatric Association (APA). 1994. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Press.
American Psychiatric Association (APA). 2000. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: APA.
American Psychiatric Association (APA). 2001. The practice of ECT: Recommendations for treatment, training and privileging. Washington, DC: American Psychiatric Press.
American Psychiatric Association (APA). 2001. The practice of electroconvulsive therapy: Recommendations for treatment, training and privileging, 2nd edn. Washington, DC: APA.
American Psychiatric Association (APA). 2001. The practice of electroconvulsive therapy: Recommendations for treatment, training and privileging. Washington, DC: APA.
American Psychiatric Association (APA). 2001. The practice of electroconvulsive therapy: Recommendations for treatment, training and privileging: A task force report of the American Psychiatric Association, 2nd edn. Washington, DC: American Psychiatric Association.
American Psychiatric Association Committee on ECT. 2001. Electroconvulsive therapy: Recommendations for treatment, training, and privileging, 2nd edn. Washington, DC: American Psychiatric Press.
American Psychiatric Association Committee on Electroconvulsive Therapy. 2001. The practice of electroconvulsive therapy: Recommendations for treatment, training and privileging. (A task force report of the American Psychiatric Association). Washington, DC: American Psychiatric Press.
American Psychiatric Association Task Force on ECT. 1990. The practice of ECT: Recommendations for treatment, training and privileging. Washington, DC: American Psychiatric Press.
American Psychiatric Association Task Force on ECT. 2001. The practice of electroconvulsive therapy: Recommendations for treatment, training, and privileging, 2nd edn. Washington, DC: American Psychiatric Association.
American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, 4th edn-text revision. Washington, DC: American Psychiatric Association.
American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, 4th edn., Text Revision. Washington, DC, American Psychiatric Association.
American Psychiatric Association. 2001. Practice of electroconvulsive therapy: Recommendations of treatment, training, and privileging, 2nd edn. A task force report of the American Psychiatric Association. Washington, DC: American Psychiatric Association.
American Psychiatric Association. 2001. The practice of ECT: Recommendations for treatment, training, and privileging, 2nd edn. Washington DC: American Psychiatric Press.
American Psychiatric Association. The practice of ECT: Recommendations for treatment, training, and privileging, 2nd edn. Washington, DC: American Psychiatric Press, 2001.
Amsterdam, J. D. and Shults, J. 2005. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression – lack of manic induction. J Affect Disord 87: 121–30.
Anderson, D. and Ahmed, A. 2003. Treatment of patients with intractable obsessive-compulsive disorder with anterior capsular stimulation. Case report. J Neurosurg 98(5): 1104–8.
Andersson, J. E. and Bolwig, T. G. 2002. Electroconvulsive therapy in Denmark 1999. A nation-wide questionnaire study. Ugeskr Laeger 164(26): 3449–52.
Andrade, C. 2003. Unmodified ECT: Ethical issues. Issues Med Ethics 11(1): 9–10.
Andrade, C. and Kurinji, S. 2002. Continuation and maintenance ECT: A review of recent research. J ECT 18(3): 149–58.
Andrade, C. and Rao, N. S. 1996. Medical students' attitudes toward electroconvulsive therapy: An Indian perspective. Convuls Ther 12(2): 86–90.
Andrade, C. and Thyagarajan, S. 2007. The influence of name on the acceptability of ECT: The importance of political correctness. J ECT 23: 75–7.
Andreescu, C., Lenze, E. J., Dew, M. A., et al. 2007. Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: Controlled study. Br J Psychiatry 190: 344–9.
Andreescu, C., Mulsant, B. H., Peasley-Miklus, C., et al. 2007. STOP-PD Study Group. Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features. J Clin Psychiatry 68: 194–200.
Andrews, M. and Hasking, P. 2004. Effect of two educational interventions on knowledge and attitudes towards electroconvulsive therapy. J ECT 20(4): 230–6.
Andrews, M. and Hasking, P. 2004. Effect of two educational interventions on knowledge and attitudes towards electroconvulsive therapy. J ECT 20: 230–6.
Angelucci, F., Aloe, L., Jiménez-Vasquez, P., and Mathé, A. A. 2003. Electroconvulsive stimuli alter nerve growth factor but not brain-derived neurotrophic factor concentrations in brains of a rat model of depression. Neuropeptides 37: 51–6.
Anghelescu, I., Klawe, C. J., Bartenstein, P., and Szegedi, A. 2001. Normal PET after long-term ECT. Am J Psychiatry 158: 1527.
Antal, A., Nitsche, M. A., Kruse, W., et al. 2004. Direct current stimulation over V5 enhances visuomotor coordination by improving motion perception in humans. J Cogn Neurosci 16: 521–7.
Anton, A. H., Uy, D. S., and Redderson, C. L. 1977. Autonomic blockade and the cardiovascular and catecholamine response to electroshock. Anesth Analg 56: 46–54.
Aouizerate, B., Cuny, E., Martin-Guehl, C., et al. 2004. Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg 101: 574–5.
Appelbaum, P. S. 2007. Clinical practice. Assessment of patients' competence to consent to treatment. N Engl J Med 357: 1834–40.
Appelbaum, P. S. and Grisso, T. 1995. The MacArthur Treatment Competence Study. I. Law Hum Behav 19: 105–26.
Appelbaum, P. S., Grisso, T., Frank, E., et al. 1999. Competence of depressed patients for consent to research. Am J Psychiatry 156(9): 1380–4.
Appelbaum, P. S., Lidz, C. W., and Meisel, A. 1987. Informed consent. New York: Oxford University Press.
Arato, M., Erdos, A., Kurcz, M., et al. 1980. Studies on the prolactin response induced by electroconvulsive therapy in schizophrenics. Acta Psychiatr Scand 61: 239–44.
Arce, L. 1970. Indoklon: convulsive therapy: Experimental-clinical studies. Psychosomatics 11: 358–60.
Arnold, O. H. and Stepan, H. 1952. Untersuchungen zur Frage der akuten todlicken Katatonie. Wien Z Nervenheilkd Grenzgeb 4: 235–58.
Arnold, W. 1978. Shadowland. New York: McGraw-Hill Education.
Aronson, T. A., Shukla, S., and Hoff, A. 1987. Continuation therapy after ECT for delusional depression: A naturalistic study of prophylactic treatments and relapse. Convuls Ther 3: 251–9.
Aronson, T. A., Shukla, S., Hoff, A., and Cook, B. 1988. Proposed delusional depression subtypes: Preliminary evidence from a retrospective study of phenomenology and treatment course. J Affect Disord 14: 69–74.
Atze Akkerman and Elizabeth Akkerman v. Joseph Johnson, Santa Barbara Cottage Hospital et al. 2005. In 1069713 Superior Court of the State of California for the County of Santa Barbara.
Atze Akkerman v. Mecta Corporation, Inc. 2007. In 2d Civil No. B192109 Court of Appeal of the State of California Second Appellate District.
Auquier, P., Hodgkinson, M., Thirion, X., and Tramoni, A. V. 1994. Attitude of psychiatrists to electrotherapy. Encephale 20: 713–7.
Auriacombe, M., Rénéric, J. P., Usandizaga, D., et al. 2000. Post-ECT agitation and plasma lactate concentrations. J ECT 16: 263–7.
Auriacombe, M., Reneric, J. P., Usandizaga, D., et al. 2000. Post-ECT agitation and plasma lactate concentrations. J ECT 16(3): 263–7.
Avedis, H. H. (Director). 1980. The fifth floor [Motion picture]. United States: Hickmar Productions.
Avery, D. and Lubrano, A. 1979. Depression treated with imipramine and ECT: The DeCarolis study reconsidered. Am J Psychiatry 136: 559–62.
Avery, D. and Winokur, G. 1976. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 33: 1029–37.
Avramov, M. N., Husain M. M., and White, P. F. 1995. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg 81(3): 596–602.
Aziz, M., Mehringer, A. M., Mozurkewich, E., and Razik, G. N. 2005. Cost-utility of 2 maintenance treatments for older adults with depression who responded to a course of electroconvulsive therapy: Results from a decision analytic model. Can J Psychiatry 50(7): 389–97.
Azuma, H., Fujita, A., Otsuki, K., et al. 2007. Ictal electroencephalographic correlates of posttreatment neuropsychological changes in electroconvulsive therapy: A hypothesis-generation study. J ECT 23(3): 163–8.
Babayan, E. A. 1978. Legal aspects of psychiatry in legislation of the USSR [in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova 78(4): 598–603.
Babigian, H. M. and Guttmacher, L. B. 1984. Epidemiologic considerations in electroconvulsive therapy. Arch Gen Psychiatry 41: 246–53.
Bagadia, V. N., Abhyankar, R. R., Doshi, J., et al. 1983. A double blind controlled study of ECT vs. chlorpromazine in schizophrenia. J Assoc Phys of India 31: 637–40.
Baghai, T. C., Frey, R., Kasper, S., and Moller, H. J. 2004. Elektrokonvulsionstherapie: Klinische und wissenschaftliche Aspekte. Vienna: Springer-Verlag.
Baghai, T. C., Marcuse, A., Moller, H. J., and Rupprecht, R. 2005. Electroconvulsive therapy at the Department of Psychiatry and Psychotherapy, University of Munich. Development during the years 1995–2002. Nervenarzt 76: 597–612.
Bailine, S. H. and Rau, J. H. 1981. The decision to use ECT: A retrospective study. Compr Psychiatry 22: 274–81.
Bailine, S. H., Petrides, G., Doft, M., and Lui, G. 2003. Indications for the use of propofol in electroconvulsive therapy. J ECT 19(3): 129–32.
Bailine, S. H., Rifkin, A., Kayne, E., et al. 2000. Comparison of bifrontal and bitemporal ECT for major depression. Am J Psychiatry 157: 121–3.
Bailine, S. H., Rifkin, A., Kayne, E., et al. 2000. Comparison of bifrontal and bitemporal ECT for major depression. Am J Psychiatry 157: 121–3.
Bailine, S. H., Safferman, A., Vital-Herne, J., et al. 1994. Flumazenil reversal of benzodiazepine-induced sedation for a patient with severe pre-ECT anxiety. Convuls Ther 10: 65–8.
Bain, A. J. 1940. The influence of Cardiazol on chronic schizophrenia. J Ment Sci 86: 502–13.
Bajc, M., Medved, V., Basic, M., et al. 1989. Acute effect of electroconvulsive therapy on brain perfusion assessed by 99mTc-hexamethylpropyleneamineoxim and single photon emission computed tomography. Acta Psychiatr Scand 80: 421–6.
Banschikov, V. M. and Nevzorova, T. A. 1969. Psychiatry [in Russian]. Moscow: Meditsina, 344 pp.
Banschikov, V. M. and Rapoport, A. M. 1952. Electroconvulsive therapy in psycho-neurological hospitals of the USSR [in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova 52(3): 67–81.
Barber, S. 1993. Antonin Artaud, blows and bombs. London: Faber & Faber.
Barker, A. T. 2002. The history and basic principles of magnetic nerve stimulation. In Handbook of transcranial magnetic stimulation, 1st edn. (eds. Pascual-Leone, A., Davey, N., Rothwell, J., et al.). New York: Oxford University Press, pp. 3–17.
Barker, M. J., Greenwood, K. M., Jackson, M., Crowe, S. F. 2005. An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use. J Int Neuropsychol Soc 11: 281–9.
Barker, M. J., Greenwood, K. M., Jackson, M., et al. 2004. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: A meta-analysis. Arch Clin Neuropsychol 19: 437–54.
Barnes, R. C., Hussein, A., Anderson, D. N., and Powell D. 1997. Maintenance electroconvulsive therapy and cognitive function. Br J Psychiatry 170: 285–7.
Barnes, R. C., Hussein, A., Anderson, D. N., and Powell, D. 1997. Maintenance electroconvulsive therapy and cognitive function. Br J Psychiatry 170: 285–7.
Bassett, S. S. 2005. Cognitive impairment in Parkinson's disease. Prim Psychiatry 12: 50–5.
Battersby, M., Ben-Tovim, D. and Eden, J. 1993. Electroconvulsive therapy: A study of attitudes and attitude change after seeing an educational video. Aust N Z J Psychiatry 27: 613–19.
Baudis, P. 1992. Electroconvulsive therapy in the Czech Republic 1981–1989. Cesk Psychiatr 88: 41–7.
Baxter, L. R. 1990. Brain imaging as a tool in establishing a theory of brain pathology in obsessive compulsive disorder. J Clin Psychiatry 51 Suppl: 22–5; discussion 26.
Baxter, L. R., Clark, E. C., and Iqbal, M., 2001. Cortical-subcortical systems in the mediation of OCD: Modeling the brain's mediation of a classic “neurosis.” In Frontal-subcortical circuits in psychiatric and neurological disorders (eds. Lichter, D. G. and Cummings, J. L.). New York: Guilford Press, pp. 207–30.
Baxter, L. R., Schwartz, J. M., Phelps, M. E., et al. 1989. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46: 243–50.
Beck, A. T., Steer, R. A., and Garbin, M. G. 1988. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 8: 77–100.
Beekman, A. T., de Beurs, E., van Balkom, A. J., et al. 2000. Anxiety and depression in later life: Co-occurrence and communality of risk factors. Am J Psychiatry 157: 89–95.
Behrman, A. 2002. Electroboy. New York: Penguin.
Bellinger, C. H. 1939. Discussion. Psychiatr Q 13: 569–73.
Belmaker, R. H. and Agam, G. 2008. Major depressive disorder. N Engl J Med 358(1): 55–68.
Ben-Menachem, E., Hamberger, A., Hedner, T., et al. 1995. Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res 20: 221–7.
Ben-Menachem, E., Manon-Espaillat, R., Ristanovic, R., et al. 1994. Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia 35: 616–26.
Benabid, A. L., Pollak, P., Louveau, A., et al. 1987. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 50(1–6): 344–6.
Benadhira, R. and Teles, A. 2001. Current status of electroconvulsive therapy in adult psychiatric care in France. Encephale 27: 129–36.
Bench, C. J., Friston, K. J., Brown, R. G., et al. 1993. Regional cerebral blood flow in depression measured by positron emission tomography: The relationship with clinical dimensions. Psychol Med 23: 579–90.
Bennett, A. 2005. Untold stories. London: Faber & Faber, pp. 32–109.
Bennett, A. E. 1940a. Metrazol convulsive shock therapy in affective psychoses: A follow up report of results obtained in 61 depressive and 9 manic cases. Am J Med Sci 198: 695–701.
Bennett, A. E. 1940b. Preventing traumatic complications in convulsive shock therapy by curare. JAMA 114: 322–4.
Berg, S. and Robbins, E. S. 1959. A pharmacological report on PM-1090. J Neuropsychiatr, 1: 32–4.
Bergsholm, P. 1995. Electroconvulsive therapy. Issues related to narcosis, physiology, radiological anatomy, electrode placement, endocrinology. Ph.D. Dissertation, University of Bergen.
Bergsholm, P., Bleie, H., Gran, L., and d'Elia, G. 1993. Cardiovascular response and seizure duration as determined by electroencephalography during unilateral electroconvulsive therapy. Acta Psychiatr Scand 88: 25–8.
Bergsholm, P., Gran, L., and Bleie, H. 1984. Seizure duration in unilateral electroconvulsive therapy. The effect of hypocapnia induced by hyperventilation and the effect of ventilation with oxygen. Acta Psychiatr Scand 69(2): 121–8.
Bergsholm, P., Gran, L., and Bleie, H. 1984. Seizure duration in unilateral electroconvulsive therapy. The effect of hypocapnia induced by hyperventilation and the effect of ventilation with oxygen. Acta Psychiatr Scand 69: 121–8.
Berigan, T. R., Harazin, J., and Williams, H. L. 2nd. 1995. Use of flumazenil in conjunction with electroconvulsive therapy. Am J Psychiatry 152: 957.
Berman, R. M., Narasimhan, M., Sanacora, G., et al. 2000. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry 47: 332–7.
Bernardo M, Arrufat F, Pintor L, Catarineu S, Buisan E, Ballus C. 1996. Patterns of the use of electroconvulsive therapy in Barcelona. Med Clin (Barc) 106: 201–4.
Bernardo, M., Catarineu, S., Minarro, A., et al. 1993. Actitudes de los médicos anestesiologos ante la terapia electroconvulsiva. Rev Psiquiatria Fac Med Barna 20: 108–12.
Berrios, G. E. 1979. Insanity and epilepsy in the nineteenth century. In Psychiatry, genetics and pathography: A tribute to Eliot Slater (eds. Roth, M. and Cowie, V.). London: Gaskell.
Berson, S. A. and Yalow, R. S. 1968. Radioimmunoassay of ACTH in plasma. J Clin Invest 47: 2725–51.
Bertolín-Guillén, J. M., Peiró-Moreno, S., and Hernández-de-Pablo, M. E. 2006. Patterns of electroconvulsive therapy use in Spain. Eur Psychiatry 21(7): 463–70.
Bertolin-Guillen, J. M., Peiro, M. S., Hernandez De Pablo, M. E., and Saez, A. C. 2001. Variability in attitudes and used conditions of electroconvulsive therapy. Results of a preliminary study. Actas Esp Psiquiatr 29: 390–5.
Bertolin-Guillen, J. M., Peiro-Moreno, S., and Hernandez-de-Pablo, M. E. 2006. Patterns of electroconvulsive therapy use in Spain. Eur Psychiatry 21: 463–70.
Berton, O. and Nestler, E. J. 2006. New approaches to antidepressant drug discovery: Beyond monoamines. Nat Rev Neurosci 7: 137–51.
Beurrier, C., B. Bioulac, Audin, J., and Hammond, C. 2001. High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons. J Neurophysiol 85(4): 1351–6.
Bhat, S. K., Acosta, D., and Swartz, C. M. 2002. Postictal asystole during ECT. J ECT 18: 103–6.
Bhat, T., Pande, N., Shah, N., and Andrade C. 2007. Safety of repeated courses of electroconvulsive therapy in a patient with Harrington rods. J ECT 23(2): 106–8.
Bianchi, J. A. and Chiarello, C. J. 1945. Shock therapy in the involutional and manic-depressive psychoses. Psychiatr Q 18: 118–27.
Bickford, R. G., Guidie, N., Fertesque, P., and Svenson, M. 1987. Magnetic stimulation of human peripheral nerve and brain: Response and enhancement by combined magneto electrical technique. Neurosurgery 20: 110–16.
Bigelow, H. J. 1850. Dr. Harlow's case of recovery from the passage of an iron bar through the head. Am J Med Sci 20: 13–22.
Bijak, M., Zahorodna, A., and Tokarski, K. 2001. Opposite effects of antidepressants and corticosterone on the sensitivity of hippocampal CA1 neurons to 5-HT1A and 5-HT4 receptor activation. Naunyn Schmiedebergs Arch Pharmacol 363: 491–8.
Binder, D. K. 2007. Neurotrophins in the dentate gyrus. Prog Brain Res 163: 371–97.
Bindman, L. J., Lippold, O. C., and Redfearn, J. W. 1964. The action of brief polarizing currents on the cerebral cortex of the rat (1) during current flow and (2) in the production of long-lasting after-effects. J Physiol 172: 369–82.
Bini, L. 1937. Richerche sperimentali nell'accesso epilettico da corrente elettrica. Schweizer Arch Neurol Psychiatr 39(supplement): 121–2.
Bini, L. 1940. La tecnica e le manifestazioni dell'elettroshock. Riv Sper Freniatr Med Leg Alien Ment 64: 361–458.
Birkenaes, A. B., Birkeland, K. I., Engh, J. A., et al. 2008. Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions. J Clin Psychopharmacol 28: 132–7.
Birkenaes, A. B., Opjordsmoen, S., Brunborg, C., et al. 2007. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: A comparative study. J Clin Psychiatry 68: 917–23.
Birkenhager, T. K., van den Broek, W. W., Mulder, P. G., and De Lely, A. 2005. One-year outcome of psychotic depression after successful electroconvulsive therapy. J ECT 21: 221–6.
Biswal, B., Yetkin, F. Z., Haughton, V. M., and Hyde, J. S. 1995. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 34: 537–41.
Blachly, P. 1976. New developments in electroconvulsive therapy. Dis Nerv Syst 37: 356–8.
Blachly, P. and Gowing, D. 1966. Multiple monitored electroconvulsive treatment. Compr Psychiatry 7: 100–9.
Blaurock, M. F., Low, A. A., and Sachs, M. 1939. Influence of fear, pharmacological action and convulsion in metrazol therapy. Arch Neurol Psychiatry 42: 233–6.
Bleckwinn, W. J., Hodgson, E. R., and Herwick, R. P. 1940. Clinical comparison of picotroxin, metrazol and coriamyrtin used as analystics and as convulsants. J Pharmacol Exp Ther 69: 81–8.
Bleuler, E. 1924. Textbook of psychiatry. New York: Macmillan.
Blier, P. and Bouchard, C. 1992. Effect of repeated electroconvulsive shocks on serotonergic neurons. Eur J Pharmacol 211: 365–73.
Bliss, T. V. and Collingridge, G. L. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31–9.
Bloch, Y., Levcovitch, Y., Bloch, A. M., et al. 2001. Electroconvulsive therapy in adolescents: Similarities to and differences from adults. J Am Acad Child Adolesc Psychiatry 40: 1332–6.
Blumberg, H. P., Stern, E., Martinez, D., et al. 2000. Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry 48: 1045–52.
Blumberg, H. P., Stern, E., Ricketts, S., et al. 1999. Rostral and orbital prefrontal dysfunction in the manic state of bipolar disorder. Am J Psychiatry 156: 1986–88.
Blumenfeld, H., McNally, K. A., Ostroff, R. B., and Zubal, I. G. 2003. Targeted prefrontal cortical activation with bifrontal ECT. Psychiatry Res 123(3): 165–70.
Blumenfeld, H., McNally, K. A., Ostroff, R. B., and Zubal, I. G. 2003a. Targeted prefrontal cortical activation with bifrontal ECT. Psychiatry Res 123: 165–70.
Blumenfeld, H., Westerveld, M., Ostroff, R. B., et al. 2003b. Selective frontal, parietal, and temporal networks in generalized seizures. Neuroimage 19: 1556–66.
Bockris, V. 1995. Transformer, the Lou Reed story. New York: Simon & Schuster.
Boggio, P. S., Ferrucci, R., Rigonatti, S. P., Covre, P., Nitsche, M., Pascual-Leone, A., et al. 2006. Effects of transcranial direct current stimulation on working memory in patients with Parkinson's disease. J Neurol Sci 249: 31–38.
Boggio, P. S., Rigonatti, S. P., Ribeiro, R. B., et al. 2007. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol 11(2): 1–6.
Boggio, P. S., Sultani, N., Fecteau, S., et al. 2008. Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: A double-blind, sham-controlled study. Drug Alcohol Depend 92(1–3): 55–60. Epub 2007 Jul 19.
Bolwig, T. G. and Madsen, T. M. 2007. Electroconvulsive therapy in melancholia: The role of hippocampal neurogenesis. Acta Psychiatr Scand Suppl (433): 130–5.
Bolwig, T. G. and Madsen, T. M. 2007. Electroconvulsive therapy in melancholia: The role of hippocampal neurogenesis. Acta Psychiatr Scand Suppl 433: 130–5.
Bolwig, T. G., Hertz, M. M., Paulson, O. B., et al. 1977. The permeability of the blood-brain barrier during electrically induced seizures in man. Eur J Clin Invest 7: 87–93.
Bolwig, T. G., Woldbye, D. P., and Mikkelsen, J. D. 1999. Electroconvulsive therapy as an anticonvulsant: a possible role of neuropeptide Y (NPY). J ECT 15: 93–101.
Bolwig, T., Wahlund, B., Kho, K. H., and Sienaert, P. 2006. A European foundation for electroconvulsive therapy. J ECT 22: 91.
Bond, E. D. and Rivers, T. D. 1944. Insulin shock therapy after seven years. Am J Psychiatry 101: 62–3.
Bonne, O. and Krausz, Y. 1997. Pathophysiological significance of cerebral perfusion abnormalities in major depression-trait or state marker? Eur Neuropsychopharmacol 7: 225–33.
Bonne, O., Krausz, Y., Shapira, B., et al. 1996. Increased brain Tc-99m HMPAO uptake in depressed patients who have responded to electroconvulsive therapy. J Nucl Med 37: 1075–80.
Bonne, O., Krausz, Y., Shapira, B., et al. 1996. Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. J Nucl Med 37(7): 1075–80.
Borzunova, A. S. 1952. About pathogenesis of epilepsy and schizophrenia in connection with their treatment with convulsive remedies [in Russian]. Abstract of Ph.D. Dissertation, Ufa, Psychiatric Clynic of Bashkir Medical Institute, 16 pp.
Bourgeois, M., Palem, R., Tignol, J., et al. 1981. Current status of electroconvulsive therapy (ECT). I. Numerical aspects, indications, efficacy, media, prejudices and ideologies. Ann Med Psychol (Paris) 139: 1122–35.
Bourgon, L. N. and Kellner, C. H. 2000. Relapse of depression after ECT: A review. J ECT 16(1): 19–31.
Bourn, H. 1953. The insulin myth. Lancet ii: 964–8.
Bowdler, J. M., Green, A. R., Minchin, M. C., and Nutt, D. J. 1983. Regional GABA concentration and [3H]-diazepam binding in rat brain following repeated electroconvulsive shock. J Neural Transm 56: 3–12.
Boyarsky, B. K., Fuller, M., and Early, T. 1999. Malignant catatonia-induced respiratory failure with response to ECT. J ECT 15: 232–6.
Boylan, L. S., Haskett, R. F., Mulsant, B. H., et al. 2000. Determinants of seizure threshold in ECT: Benzodiazepine use, anesthetic dosage, and other factors. J ECT 16(1): 3–18.
Bozkurt, A., Karlidere, T., Isintas, M., et al. 2007. Acute and maintenance electroconvulsive therapy for treatment of psychotic depression in a pregnant patient. J ECT 23(3): 185–7.
Braga, R. J. and Petrides, G. 2005. The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia. J ECT 21: 75–83.
Bragina, N. N. and Dobrokhotova, T. A. 1981. Human functional asymmetries. Moscow: Meditsina (Russian).
Braitenberg, V. and Schüz, A. 1998. Cortex: Statistics and geometry of neuronal connectivity, 2nd edn. Berlin: Springer.
Brakel, S. and Rock, R. 1971. The mentally disabled and the law. Chicago: University of Chicago Press.
Brakemeier, E. L., Luborzewski, A., Danker-Hopfe, H., et al. 2007. Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). J Psychiatr Res 41(5): 395–403.
Brandon, S., Cowley, P., McDonald, C., et al. 1984. Electroconvulsive therapy: Results in depressive illness from the Leicestershire trial. BMJ 288: 22–25.
Brandon, S., Cowley, P., McDonald, C., et al. 1984. Electroconvulsive therapy: Results in depressive illness from the Leicestershire trial. Br Med J (Clin Res Ed) 288(6410): 22–5.
Brandon, S., Cowley, P., McDonald, C., et al. 1985. Leicester ECT trial: Results in schizophrenia. Br J Psychiatry 146: 177–83.
Brasic, J. R., Zagzag, D., Kowalik, S., et al. 2000. Clinical manifestations of progressive catatonia. German J Psychiatry 3: 13–24.
Braslow, J. 1997. Mental ills and bodily cures, psychiatric treatment in the first half of the twentieth century. Berkeley: University of California Press, pp. 95–124.
Braslow, J. 1997. Mental ills and bodily cures: Psychiatric treatment in the first half of the twentieth century. Berkeley: University of California Press.
Breakey, W. R. and Dunn, G. J. 2004. Racial disparity in the use of ECT for affective disorders. Am J Psychiatry 161: 1635–41.
Breakey, W. R. and Kala, A. K. 1977. Typhoid catatonia responsive to ECT. BMJ 2: 357–9.
Brill, N. Q., Crumpton, E., Eiduson, S., et al. 1959. Predictive and concomitant variables related to improvement with actual and simulated ECT. Arch Gen Psychiatry 1: 263–72.
Brill, N. Q., Crumpton, E., Eiduson, S., et al. 1959. Relative effectiveness of various components of electroconvulsive therapy. Arch Neurol Psychiatry 81: 627–35.
Brodersen, P., Paulson, O. B., Bolwig, T. G., et al. 1973. Cerebral hyperemia in electrically induced epileptic seizures. Arch Neurol 28: 334–8.
Brody, E. B. 1966. On the psychiatry of Latin America. Am J Psychiatry, 123: 475–7.
Bromberg, W. 1979. The uses of psychiatry in the law: Clinical view of forensic psychiatry. Westport, CT: Quorum Books.
Brown, M. R. and Fisher, L. A. 1984. CRF: Integration of the neuroendocrine and autonomic nervous system responses to stress. In Endocrinology (eds. Labrie, F. and Proulx, F.). New York: Excerpta Medica International Congress Series 655, pp. 597–600.
Brown, N. I., Mack, P. F., Mitera, D. M., and Dhar, P. 2003. Use of the ProSeal laryngeal mask airway in a pregnant patient with a difficult airway during electroconvulsive therapy. Br J Anaesth 91(5): 752–4.
Brown, R. P., Frances, A., Kocsis, J. H., and Mann, J. J. 1982. Psychotic vs. nonpsychotic depression: Comparison of treatment response. J Nerv Ment Dis 170: 635–7.
Bruce, E. M., Crone, N., Fitzpatrick, G., et al. 1960. A comparative trial of ECT and tofranil. Am J Psychiatry 117: 76.
Brunelin, J., Poulet, E., Bediou, B., et al. 2006. Low frequency repetitive transcranial magnetic stimulation improves source monitoring deficit in hallucinating patients with schizophrenia. Schizophr Res 81(1): 41–5. Epub 2005 November 28.
Bruno, A. U. 1941. Resultados obtenidos en clínica psiquiátrica con el empleo de los métodos modernos de shockterapia en cuatro años de experiencia personal. Rev Psiquiatr Urug 6(35): 33–8.
Buffett-Jerrott, S. E. and Stewart, S. H. 2002. Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des 8: 45–58.
Buhl, C., Riaux, A., Andraud, F., et al. 2007. Nine-year prophylactic maintenance electroconvulsive therapy in an 89-year-old woman with recurrent psychotic major depressive disorder. Am J Geriatr Psychiatry 15(4): 357.
Bumke, O. 1929. Lehrbuch des Geisteskrankheiten. München: Bergmann.
Burke, M. J. and Husain, M. M. 2006. Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression. J ECT 22(3): 218–22.
Burnet, P. W., Sharp, T., LeCorre, S. M., and Harrison, P. J. 1999. Expression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock. Neurosci Lett 277: 79–82.
Burnstein, R. M. and Denny, N. 1993. Mivacurium in electroconvulsive therapy. Anaesthesia 48(12): 1116.
Butler, S. M., Ashford, J. W., and Snowdon, D. A. 1996. Age, education and changes in the Mini-Mental State Exam scores of older women: Findings from the Nun Study. J Am Geriatr Soc 44: 675–81.
Byrne, D. J., Napier, A., and Cuschieri, A. 1988. How informed is signed consent? Br Med J (Clin Res Ed) 296: 839–40.
Byrne, P., Cassidy, B., and Higgins, P. 2006. Knowledge and attitudes toward electroconvulsive therapy among health care professionals and students. J ECT 22(2): 133–8.
Cairns, R., Maddock, C., Buchanan, A., et al. 2005. Prevalence and predictors of mental incapacity in psychiatric in-patients. Br J Psychiatry 187: 379–85.
Calev, A., Ben-Tzvi, E., Schapira, B., et al. 1989. Distinct memory impairments following electroconvulsive therapy and imipramine. Psychol Med 19: 111–19.
Calev, A., Cohen, R., Tubi, N., et al. 1991. Disorientation and bilateral moderately suprathreshold titrated ECT. Convuls Ther 7: 99–110.
Calev, A., Cohen, R., Tubi, N., et al. 1991. Disorientation and bilateral moderately suprathreshold titrated ECT. Convuls Ther 7: 99–110.
Calev, A., Gaudino, E. A., Aquires, N. K., et al. 1995. ECT and non-memory cognition: A review. Br J Clin Psychol 34: 505–15.
California Assembly Bill No. 1032, 1976.
California Code of Regulations (CCR), Title 17 can be found at http://www.oal.ca.gov/index.html
California Code of Regulations (CCR), Title 9 can be found at http://www.oal.ca.gov/index.html
California Welfare and Institutions Code, Section 5326, West Supp., 1971.
Campagna J. A. 2006. Development of the neuromuscular junction. Int Anesthiol Clin 44(2): 1–20.
Campion, J. (Director). 1990. Angel at my table. [Motion picture]. UK: Australian Broadcasting Corporation.
Capasso, R. M., Lineberry, T. W., Bostwick, J. M., et al. 2008. Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950–2005. Schizophr Res 98(1–3): 287–94.
Carlezon, W. A. Jr, Duman, R. S., and Nestler, E. J. 2005. The many faces of CREB. Trends Neurosci 28: 436–45.
Carllarge, C., Crowe, R., Gergis, S., et al. 2003. The comparative effects of sevoflurane and methohexital for electroconvulsive therapy. J ECT 19(4): 221–5.
Carney, M. W. P., Roth, M., and Garside, R. F. 1965. The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatry 111: 659–74.
Caroff, S. N. and Ungvari, G. S. 2007. Expanding horizons in catatonia research. Psychiatr Ann 37: 7–9.
Caroff, S. N., Mann, S. C., Campbell, E. C., and Sullivan, K. A. 2004. Epidemiology. In Catatonia: From psychopathology to neurobiology (eds. Caroff, S. N., Mann, S. C., Francis, A., and Fricchione, G. L.). Washington, DC: American Psychiatric Press, pp. 15–31.
Caroff, S. N., Ungvari, G. S., Bhati, M. T., et al. 2007. Catatonia and prediction of response to electroconvulsive therapy. Psychiatr Ann 37: 57–64.
Carpenter, W. T. Jr. and Buchanan, R. W. 1994. Schizophrenia. N Engl J Med 330: 681–90.
Casarotti, H., Otegui, J., Savi, G., et al. 2004. Electroconvulsoterapia: Fundamentos y pautas de utilización. Rev Psiquiatr Urug 68(1): 7–41.
Castellanos, F. X., Margulies, D. S., Kelly, C., et al. 2008. Cingulate-precuneus interactions: A new locus of dysfunction in adult attention-deficit/hyperactivity disorder. Biol Psychiatry 63: 332–7.
Castelli, I., Steiner, L. A., Kaufman, M. A., et al. 1995. Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy. Anesth Analg 80(3): 557–61.
Cavett, D. 1992, August 3. Goodbye, Darkness. People.
Cerletti U. 1940. l'Elettroshock. Riv Sper Freniatr Med Leg Alien Ment 64: 209–310.
Cerletti, U. 1947. Sostanze di estrema difesa prodotte dall'elettroshock(acroagonine). Il Lavoro Neuropsichiatrico 1: 367–99.
Cerletti, U. 1950. Old and new information about electroshock. Am J Psychiatry 107: 87–94.
Cerletti, U. and Bini, L. 1938. Un nuevo metodo di shockterapie “l'elettro-shock.” Bollettino Accademia Medica Roma 64: 136–8.
Cerletti, U. and Bini, L. 1938. Un nuovo metodo di shockterapie: ‘l'elettroshock’ (riassunto). Communicazione alla seduta del 28 maggio 1938–XVI della Reale Accademia Medica di Roma. Rome: Reale Accademia Medica.
Chadio, S. E. and Antoni, F. A. 1993. Specific oxytocin agonist stimulates prolactin release but has no effect on inositol phosphate accumulation in isolated rat anterior pituitary cells. J Mol Endocrinol 10: 107–12.
Chamberlin, E. and Tsai, G. E. 1998. A glutamatergic model of ECT-induced memory dysfunction. Harv Rev Psychiatry 5: 307–17.
Chambers, C. D., Johnson, K. A., Dick, L. M., et al. 1996. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335(14): 1010–15.
Chang, S., Chang, I.-S., and Lin, K.-M. 2006. Electroconvulsive therapy (ECT) usage in Taiwan. Annual Meeting of Taiwanese Society of Psychiatry (Symposium #20).
Chanpattana, W. 1997. Continuation electroconvulsive therapy in schizophrenia: A pilot study. J Med Assoc Thai 80: 311–18.
Chanpattana, W. 1998. Maintenance ECT in schizophrenia: A pilot study. J Med Assoc Thai 81: 17–24.
Chanpattana, W. 2000. Maintenance ECT in treatment-resistant schizophrenia. J Med Assoc Thai 83: 657–62.
Chanpattana, W. 2000a. Combined ECT and clozapine in treatment-resistant mania. J ECT 16: 204–7.
Chanpattana, W. 2000b. Maintenance ECT in treatment-resistant schizophrenia. J Med Assoc Thai 83: 657–62.
Chanpattana, W. 2001. Anesthesia for ECT. German Journal of Psychiatry 4: 33–9.
Chanpattana, W. 2001. Seizure threshold in electroconvulsive therapy: Effect of instrument titration schedule. German J Psychiatry 4(3): 51–6.
Chanpattana, W. 2001. Seizure threshold in electroconvulsive therapy: Effect of instrument titration schedule. German J Psychiatry 4: 51–6.
Chanpattana, W. and Chakrabhand, M. L. S. 2001. Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: Prediction of outcome. Psychiatry Res 105: 107–15.
Chanpattana, W. and Kramer, B. A. 2003. Acute and maintenance ECT with flupenthixol in refractory schizophrenia: Sustained improvements in psychopathology, quality of life, and social outcomes. Schizophr Res 63: 189–93.
Chanpattana, W. and Kramer, B. A. 2003. Acute and maintenance ECT with flupenthixol in refractory schizophrenia: Sustained improvements in psychopathology, quality of life, and social outcomes. Schizophr Res 63: 189–93.
Chanpattana, W. and Kramer, B. A. 2004. Electroconvulsive therapy practice in Thailand. J ECT 20: 94–8.
Chanpattana, W., Chakrabhand, M. L., and Buppanharun, W. 2000a. Effects of stimulus intensity in the efficacy of bilateral ECT in schizophrenia: A preliminary study. Biol Psychiatry 48: 222–8.
Chanpattana, W., Chakrabhand, M. L., Buppanharun, W., and Sackeim, H. A. 2000. Effects of stimulus intensity on the efficacy of bilateral ECT in schizophrenia: a preliminary study. Biol Psychiatry 48: 222–8.
Chanpattana, W., Chakrabhand, M. L., Sackeim, H. A., et al. 1999. Continuation ECT in treatment-resistant schizophrenia: A controlled study. J ECT 15: 178–92.
Chanpattana, W., Chakrabhand, S., Techakasem, P., et al. 2000b. Seizure threshold in ECT: Dose titration vs. age and half age methods. J Med Assoc Thai 3: 278–83.
Chanpattana, W., Kojima. K., Kramer, B. A., et al. 2005a. ECT practice in Japan. J ECT 21: 139–44.
Chanpattana, W., Kunigiri, G., Kramer, B. A., et al. 2005b. Survey of the practice of electroconvulsive therapy in teaching hospitals in India. J ECT 21: 100–4.
Chapuis, R. 1942. Cinq ans d'insulino et de convulsivo-therapie chez 210 malades mentaux. Schweiz Arch Neurol Psychiatr 52: 1–12.
Charlton, G. E., Brinegar, W. C., and Holloway, O. R. 1942. Curare and metrazol therapy of psychoses. Arch Neurol Psychiatry 48: 267–70.
Chater, S. N. and Simpson, K. H. 1988. Effect of passive hyperventilation on seizure duration in patients undergoing electroconvulsive therapy. Br J Anaesth 60(1): 70–3.
Chatfield, M., Matthews, F. E., and Brayne, C. 2007. Medical Research Council Cognitive Function and Ageing Study. J Am Geriatr Soc 55: 1066–71.
Chee, K. T. 1992. Medico-legal implications of electroconvulsive therapy – a Singapore viewpoint. Singapore Med J 33: 271–2.
Chelminski, I., Zimmerman, M., and Mattia, J. I. 2000. Diagnosing melancholia. J Clin Psychiatry 61: 874–5.
Chen, A. C., Shin, K. H., Duman, R. S., and Sanacora, G. 2001. ECS-induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment. J ECT 17: 27–32.
Chen, J., Newton, S. S., Zeng, L., et al. 2004. Downregulation of the CCAAT-enhancer binding protein beta in deltaFosB transgenic mice and by electroconvulsive seizures. Neuropsychopharmacology 29: 23–31.
Chen, J., Zhang, Y., Kelz, M. B., et al. 2000. Induction of cyclin-dependent kinase 5 in the hippocampus by chronic electroconvulsive seizures: Role of [Delta]FosB. J Neurosci 20: 8965–71.
Chen, R., Classen, J., Gerloff, C., et al. 1997. Depression of motor cortex excitability by low frequency. Schizophr Res 81: 41–5.
Chiu, J. W. and White, P. F. 2001. Non opiod intravenous anesthesia. In Clinical anesthesia, 4th edn. (eds. Barash, P. G., Cullen, B. F., and Stoelting, R. K.).
Chouinard, G., Annable, L., and Ross-Chouinard, A. 1986. Supersensitivity psychosis and tardive dyskinesia: A survey in schizophrenic outpatients. Psychopharmacol Bull 22: 891–6.
Christensen, D. Z., Olesen, M. V., Kristiansen, H., et al. 2006. Unaltered neuropeptide Y (NPY)-stimulated [35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice. J Neurosci Res 84: 1282–91.
Christensen, P. and Hedemand, E. 1983. EEG and EMG monitored electroconvulsive therapy. Psychopharmacol Bull 19: 20–2.
Christensen, P., Kragh-Sorensen, P., Sorensen, C., et al. 1986. EEG-monitored ECT: A comparison of seizure duration under anesthesia with etomidate and thiopentone. Convuls Ther 2: 145–50.
Chung, K. 2006. Determinants of seizure threshold of electroconvulsive therapy in Chinese. J ECT 22: 100–2.
Chung, K. F. 2003. Electroconvulsive therapy in Hong Kong: Rates of use, indications, and outcome. J ECT 19: 98–102.
Ciapparelli, A., Dell'osso, L., Tundo, A., et al. 2001. Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J Clin Psychiatry 62: 552–5.
Ciapparelli, A., Paggini, R., Marazziti, D., et al. 2007. Comorbidity with axis I anxiety disorders in remitted psychotic patients 1 year after hospitalization. CNS Spectr 12: 913–19.
Clark, M. and Lubenow, G. 1975. Attack on electroshock. Newsweek (Mr 17) 85: 86.
Clarke, T. B., Coffey, C. E., Hoffman, G. W. Jr., and Weiner, R. D. 1989. Continuation therapy for depression using outpatient electroconvulsive therapy. Convuls Ther 5(4): 330–7.
Clarke, T. B., Coffey, C. E., Hoffman, G. W. Jr., and Weiner, R. D. 1989. Continuation therapy for depression using outpatient electroconvulsive therapy. Convuls Ther 5: 330–7.
Clifford, G. (Director). 1982. Frances [Motion picture]. United States. Universal.
Clifford, G. (Director). 1982. Frances [Motion picture]. United States: Brooksfilms.
Clinical Research Centre, Division of Psychiatry. 1984. The Northwick Park ECT trial. Predictors of response to real and simulated ECT. Br J Psychiatry 144: 227–37.
Clothier, J. L., Freeman, T., and Snow, L. 2001. Medical student attitudes and knowledge about ECT. J ECT 17(2): 99–101.
Cobb, S. 1938. Review of neuropsychiatry for 1938. Arch Intern Med 62: 883–99.
Coffey, C. E., Figiel, G. S., Djang, W. T., et al. 1988. Leukoencephalopathy in elderly depressed patients referred for ECT. Biol Psychiatry 24: 143–61.
Coffey, C. E., Lucke, J., Weiner, R. D., et al. 1995. Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT. Biol Psychiatry 37: 777–88.
Coffey, C. E., Lucke, J., Weiner, R. D., et al. 1995. Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT. Biol Psychiatry 37: 777–88.
Coffey, C. E., Weiner, R. D., Djang, W. T., et al. 1991. Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study. Arch Gen Psychiatry 48: 1013–21.
Cohen, D., Flament, M., Dubos, P.-F., and Basquin, M. 1999. Case series: Catatonic syndrome in young people. J Am Acad Child Adolesc Psychiatry 38: 1040–6.
Cohen, D., Nicolas, J. D., Flament, M., et al. 2005. Clinical relevance of chronic catatonic schizophrenia in children and adolescents: Evidence from a prospective naturalistic study. Schizophr Res 76: 301–8.
Cohen, D., Paillere-Martinot M.-L., and Basquin, M. 1997. Use of electroconvulsive therapy in adolescents. Convuls Ther 13: 25–31.
Cohen, D., Taieb, O., Flament, M., et al. 2000. Absence of cognitive impairment at long term follow-up in adolescents treated with ECT for severe mood disorders. Am J Psychiatry 157: 460–2.
Cohen, H., Kaplan, Z., Kotler, M., et al., 2004. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 161: 515–24.
Cohen, L. H. 1939. The therapeutic significance of fear in the Metrazol treatment of schizophrenia. Am J Psychiatry 95: 1349–57.
Cohen, R. M., Nordahl, T. E., Semple, W. E., et al. 1997. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task. Arch Gen Psychiatry 54: 481–6.
Cohen, R. M., Semple, W. E., Gross, M., et al. 1989. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology 2: 241–54.
Cole, M. 2008, January 17. Feds slam state hospital safety. The Oregonian (Portland newspaper) p. 1.
Coleman, E. A., Sackeim, H. A., Prudic, J., et al. 1996. Subjective memory complaints prior to and following electroconvulsive therapy. Biol Psychiatry 39: 346–56.
Colenda, C. C. and McCall, W. V. 1996. A statistical model predicting the seizure threshold for right unilateral ECT in 106 patients. Convuls Ther 12: 3–12.
Colenda, C. C. and McCall, W. V. 1996. A statistical model predicting the seizure threshold for right unilateral ECT in 106 patients. Convuls Ther 12: 3–12.
Colin Piana, R. and Ruiz Lopez, I. 1997. Inicios de la terapia electroconvulsiva en Mexico. Arch Neurociencias 2(1): 25–8.
Collier, D. A., Stober, G., Li, T., et al. 1996. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders. Mol Psychiatry 1: 453–60.
Colomb, H. O. and Wadsworth, G. L. 1941. An analysis of results in the Metrazol shock therapy of schizophrenia. J Nerv Ment Dis 93: 53–62.
Comeback for shock therapy? 1979. Time (N19) 114: 76.
Committee on Electroconvulsive Therapy. 2001. The practice of electroconvulsive therapy: Recommendations for treatment, training and privileging. Washington, DC: American Psychiatric Association Committee on Electroconvulsive Therapy.
Conca, A., Prapotnik, M., Peschina, W., and König, P. 2003. Simultaneous pattern of rCBF and rCMRGlu in continuation ECT: Case reports. Psychiatry Res 124(3): 191–8.
Conca, A., Prapotnik, M., Peschina, W., and Konig, P. 2003. Simultaneous pattern of rCBF and rCMRGlu in continuation ECT: Case reports. Psychiatry Res 124: 191–8.
Cook, L. C. 1938a. The range of mental reaction states influenced by Cardiazol convulsions. J Ment Sci 84: 664–7.
Cook, L. C. 1938b. Cardiazol convulsion therapy in schizophrenia. Proc R Soc Med 31: 567–84.
Coppen, A., Abou-Saleh, M. T., Milln, P., et al. 1981. Lithium continuation therapy following electroconvulsive therapy. Br J Psychiatry 139: 284–7.
Corcoran, C. D., Thomas, P., Phillips, J., et al. 2006. Vagus nerve stimulation in chronic treatment-resistant depression. Br J Psychiatry 189: 282–3.
Corona, G., Mannucci, E., Fisher, A. D., et al. 2007. Effect of hyperprolactinemia in male patients consulting for sexual dysfunction. J Sex Med 4: 1485–93.
Coryell, W. 1986. Are serial dexamethasone suppression tests useful in electroconvulsive therapy? J Affect Disord 10: 59–66.
Cott, J. 2005. On the sea of memory, a journey from forgetting to remembering. New York: Random House.
Cotterchio, M., Kreiger, N., Darlington, G., and Steingart, A. 2000. Antidepressant medication use and breast cancer. Am J Epidemiol 151: 951–7.
Council on Ethical and Judicial Affairs, 1997. Code of Medical Ethics. Chicago, IL.
Couturier, J. L. 2005. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: A systematic review and meta-analysis. J Psychiatry Neurosci 30(2): 83–90.
Craddock, N. and Owen, M. J. 2005. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 186: 364–6.
Crawford, C. D., Butler, P., and Froese, A. 1987. Arterial PaO2 and PaCO2 influence seizure duration in dogs receiving electroconvulsive therapy. Can J Anaesth 34(5): 437–41.
Crawley, J. N. and Corwin, R. L. 1994. Biological actions of cholecystokinin. Peptides 5: 731–55.
Crebbin, K., Mitford, E., Paxton, R., and Turkington, D. 2008. First-episode psychosis: An epidemiological survey comparing psychotic depression with schizophrenia. J Affect Disord 105: 117–24.
Crebbin, K., Mitford, E., Paxton, R., and Turkington, D. 2008. First-episode psychosis: An epidemiological survey comparing psychotic depression with schizophrenia. J Affect Disord 105: 117–24.
Creed, P., Froimson, L., and Mathew, L. 1995. Survey of the practice of electroconvulsive therapy in North Carolina. Convuls Ther 11: 182–7.
Cresswell, J., Rayner, L., Hood, C., and O'Sullivan, J. (eds.) 2006. The ECT Accreditation Service. Standards for the administration of ECT. Available at: http://www.rcpsych.ac.uk/PDF/The%20ECTAS%20Standards%20Dec%2006.pdf.
Cronholm, B. and Ottosson, J. 1963. The experience of memory function after electroconvulsive therapy. Br J Psychiatry 109: 251–8.
Crum, R. M., Anthony, J. C., Basssett, S. S., Folstein, M. F. 1993. Population-based norms for the Mini-Mental State Examination by age and education level. JAMA 269: 2386–91.
Cunningham, M. G., Goldstein, M., Katz, D., et al. 2006. Coalescence of psychiatry, neurology and neuropsychology: From theory to practice. Harv Rev Psychiatry 14: 127–40.
Cupello, A., Patrone, A., Robello, M., et al. 1993. Electric shock convulsions in the rabbit and brain cortex GABAA receptor function. Neurochem Res 18: 883–6.
Cyberonics, Inc. 2003. Physician's Manual. VNS Therapy (TM) Pulse Model 102 Generator and VNS Therapy (TM) Pulse Duo Model 102R Generator. Available at: http://www.vnstherapy.com/manuals/doc_download.asp?docid={E5D2100B A4C2-409B-B71C-E1CEA60FBD90}, accessed April 10, 2006.
D'Elia, G. 1970. Unilateral electroconvulsive therapy. Acta Psychiatr Scand Suppl (215): 1–98.
d'Elia, G. 1972. Memory studies in electroconvulsive therapy with different electrode placements. Brain Res 37: 364.
d'Elia, G. 1980. Unilateral electroconvulsive therapy. Acta Psychiatr Scand Suppl 215: 1–98.
d'Elia, G. and Widepalm, K. 1974. Comparison of frontoparietal and temporoparietal unilateral electroconvulsive therapy. Acta Psychiatr Scand 50: 225–32.
Dain, E. G. 1958. Distant results of electroconvulsive therapy of schizophrenia [in Russian]. In Proceedings of Chernovitskaya regional psycho-neurological hospital, Vol. 1. Chernovitsy, pp. 233–53.
Daly, J. J., Prudic, J., Devanand, D. P., et al. 2001. ECT in bipolar and unipolar depression: Differences in speed of response. Bipolar Disord 3: 95–104.
Dana-Haeri, J., Trimble, M. R., and Oxley, J. 1983. Prolactin and gonadotropin changes following generalized and partial seizures. J Neurol Neurosurg Psychiatry 46: 331–5.
Daniel, W. F. and Crovitz, H. F. 1982. Recovery of orientation after electroconvulsive therapy. Acta Psychiatr Scand 66: 421–8.
Daniel, W. F. and Crovitz, H. F. 1983a. Acute memory impairment following electroconvulsive therapy: I. Effects of electrical stimulus, waveform and number of treatments. Acta Psychiatr Scand 67: 1–7.
Daniel, W. F. and Crovitz, H. F. 1983b. Acute memory impairment following electroconvulsive therapy: II. Effects of electrode placement. Acta Psychiatr Scand 67: 57–68.
Daniel, W. F., Crovitz, H. F., and Weiner, R. D. 1987. Neuropsychological aspects of disorientation. Cortex 23: 169–87.
Dartmouth Hitchcock Medical Center Department of Psychiatry. 2001. Electroconvulsive therapy. Hanover, NH.
David, H. P. 1954. A critique of psychiatric and psychological research on insulin treatment in schizophrenia. Am J Psychiatry 110(10): 774–6.
Davidson, J., McLeod, M., Law-Yeone, B., et al. 1978. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. Arch Gen Psychiatry 35: 639–42.
Davidson, J., McLeod, M., Law-Yone, B., and Linnoila, M. 1978. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. Arch Gen Psychiatry 35: 639–42.
Dawson, J. 2005. Community treatment orders: International comparisons, May 2005. Cited in “ECT is Banned in Swiss Canton.” Available at www.ect.org/category/legislation. Accessed September 17, 2008.
Dax, C. E. 1951. Indications for shock therapy. J Ment Sci 97: 142–4.
Deakin, J. W. F., Ferrier, I. N., Crow, T. J., et al. 1983. Effects of ECT on pituitary hormone release: Relationship to seizure, clinical variables, and outcome. Br J Psychiatry 143: 618–24.
Decina, P., Sackeim, H. A., and Malitz, S. 1983. Prognostic value of serial dexamethasone suppression tests during and following ECT. Psychopharm Bull 19: 85–7.
Dekleva, K. B. and Husain, M. M. 1995. Sporadic encephalitis lethargica: A case treated successfully with ECT. J Neuropsychiatry Clin Neurosci 7: 237–9.
Department of Health, England. Electroconvulsive therapy survey covering period of January 2002 to March 2002. Available at http://www.markwalton.net/statistic.asp, accessed May, 2005, and at http://www.dh.gov.uk/en/Publicationsandstatistics/Statistics/StatisticalWorkAreas/Statisticalhealthcare/DH_4000216, accessed September 24, 2008.
Devanand, D. P., Decina, P., Sackeim, H. A., et al. 1987. Serial dexamethasone suppression tests in initial suppressors and nonsuppressors treated with electroconvulsive therapy. Biol Psychiatry 22: 463–72.
Devanand, D. P., Shapira, B., Petty, F., et al. 1995. Effects of electroconvulsive therapy on plasma GABA. Convuls Ther 11: 3–13.
Devanand, D.P., Dwork A.J., Hutchinson, E.R., et al. 1994. Does ECT alter brain structure? Am J Psychiatry 152: 1403.
Device for electroconvulsive therapy “Elikon-01.” 1987. [In Russian.] Zh Nevrol Psikhiatr Im S S Korsakova 87(11):4 (cover).
Dhossche, D. 2005. Handboek elektroconvulsietherapie. J ECT 21: 256–7.
Dhossche, D. 2007. Elektroconvulsietherapie: Aanbevelingen voor de praktijk. J ECT 23: 296.
Dhossche, D. M. and Bouman, N. H. 1997. Catatonia in an adolescent with Prader-Willi syndrome. Ann Clin Psychiatry 9: 247–53.
di Segni, M. And Cusmanich, S. 1993. Electroshock: Studio de los reparos de los psiquiatras para su uso. Rev Psiquiatr Urug, 57(326): 19–30.
Diaz, E. G. and Agramonte, E. A. G. 1987. La azarosa historia de la terapia electroconvulsivante (II Parte). Rev Hosp Psiquiatr La Habana 28(2): 227–39.
Diehl, D. J., Keshavan, M. S., Kanal, E., et al. 1994. Post-ECT increases in MRI regional T2 relaxation times and their relationship to cognitive side effects: A pilot study. Psychiatry Res 54: 177–84.
Dinan, T. G. and Barry, S. 1989. A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 80: 97–100.
Ding, Z. and White, P. F. 2002. Anesthesia for electroconvulsive therapy. Anesth Analg 94(5): 1351–64.
Ditmore, B. G., Malek-Ahmadi, P., Mills, D. M., and Wediger, R. L. 1992. Manic psychosis and catatonia stemming from systemic lupus erythematosus: Response to ECT. Convuls Ther 8: 33–7.
Dodwell, D. and Goldberg, D. 1989. A study of factors associated with response to electroconvulsive therapy in patients with schizophrenic symptoms. Br J Psychiatry 154: 635–9.
Doering, E. B. and Ball, W. A. 1995. Flumazenil before electroconvulsive therapy: Outstanding issues. Anesthesiology 83: 642–3.
Dolberg, O. T., Schreiber, S., and Grunhaus, L. 2001. Transcranial magnetic stimulation-induced switch into mania: A report of two cases. Biol Psychiatry 49(5): 468–70.
Dolenc, T. J. and Philbrick, K. L. 2007. Achieving competency in electroconvulsive therapy: A model curriculum. Acad Psychiatry 31(1): 65–7.
Dolenc, T. J. and Rasmussen, K. G. 2005. The safety of electroconvulsive therapy and lithium in combination: A case series and review of the literature. J ECT 21(3): 165–70.
Dolenc, T. J. and Rasmussen, K. G. 2005. The safety of electroconvulsive therapy and lithium in combination: A case series and review of the literature. J ECT 21: 165–70.
Dolenc, T. J., Barnes, R. D., Hayes, D. L., et al. 2004. Electroconvulsive therapy in patients with pacemakers and ICD's. PACE 27(9): 1257–63.
Dolenz, B. J. 1965. Indoklon: A clinical review. Psychosomatics 4: 200–5.
Dolenz, B. J. 1967. Flurothyl (Indoklon) side effects. Am J Psychiatry 123: 1453–5.
Dombrovski, A. Y., Mulsant, B. H., Haskett, R. P., et al. 2005. Predictors of remission after electroconvulsive therapy in unipolar major depression. J Clin Psychiatry 66: 1043–9.
Donahue, A. B. 2000. Electroconvulsive therapy and memory loss: A personal journey. J ECT 16(2): 133–43.
Donahue, A. B. 2000. Electroconvulsive therapy and memory loss: A personal journey. J ECT 16: 133–43.
Donati, R. J. and Rasenick, M. M. 2003. G protein signaling and the molecular basis of antidepressant action. Life Sci 73: 1–17.
Dostrovsky, J. O., R. Levy, Wu, J. P., et al. 2000. Microstimulation-induced inhibition of neuronal firing in human globus pallidus. J Neurophysiol 84(1): 570–4.
Douyon, R., Serby, M., Klutchko, B., et al. 1989. ECT and Parkinson's disease revisited: A “naturalistic”study. Am J Psychiatry 146: 1451–5.
Dowman, J., Patel, A., and Rajput, K. 2005. Electroconvulsive therapy: Attitudes and misconceptions. J ECT 21: 84–7.
Downs, J. M., Akiskal, H. G., and Rosenthal, T. L. 1993. Neuroleptic-induced pseudoschizoaffective disorder [Abstract 146]. Proceedings of the American Psychiatric Association Annual Meeting, p. 153 (full program on audiotape).
Dragasevic, N., Potrebić, A., Damjanović, A., et al. 2002. Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: An open study. Mov Disord 17(3): 528–32.
Dremencov, E., Gur, E., Lerer, B., and Newman, M. E. 2002. Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hypothalamus. Prog Neuropsychopharmacol Biol Psychiatry 26: 1029–34.
Dremencov, E., Gur, E., Lerer, B., and Newman, M. E. 2003. Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 27: 729–39.
Drevets, W. C. 2000. Neuroimaging studies of mood disorders. Biol Psychiatry 48: 813–29.
Drevets, W. C., Price, J. L., Simpson, J. R., et al. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824–7.
Dubin, W. R., Jaffe, R. L., Roemer, R. A., et al. 1989. Maintenance ECT in coexisting affective and neurologic disorders. Convuls Ther 5(2): 162–7.
Dubin, W. R., Jaffe, R., Roemer, R., et al. 1992. The efficacy and safety of maintenance ECT in geriatric patients. J Am Geriatr Soc 40(7): 706–9.
Duffett, R. and Lelliott, P. 1998. Auditing electroconvulsive therapy. The third cycle. Br J Psychiatry 172: 401–5.
Duffett, R., Siegert, D. R., and Lelliott, P. 1999. Electroconvulsive therapy in Wales. Psychiatr Bull R Coll Psychiatr 23: 597–601.
Dufouil, C., Clayton, D., Brayne, C., et al. 2000. Population norms for the MMSE in the very old: Estimates based on longitudinal data. Neurology 55: 1609–13.
Dukakis, K. and Tye, L. 2006. Shock: The healing power of electroconvulsive therapy. New York: Penguin Group.
Dukakis, K. and Tye, L. 2006. Shock: The healing power of electroconvulsive therapy. New York: Penguin.
Dukakis, K. and Tye, L. 2006a. Shock, the healing power of electroconvulsive therapy. New York: Avery.
Dukakis, K. and Tye, L. 2006b, September 18. ‘I Feel Good, I Feel Alive’. Newsweek.
Duman R. S., Heninger G. R., and Nestler E. J. 1997. A molecular and cellular theory of depression. Arch Gen Psychiatry. 54: 597–606.
Duman, R. S., Heniger, G. R., and Nestler, E. J. 1997. A molecular and cellular theory of depression. Arch Gen Psychiatry 54: 597–606.
Dwersteg, J. F. and Avery, D. H. 1987. Atracurium as a muscle relaxant for electroconvulsive therapy in a burned patient. Convuls Ther 3(1): 49–53.
Dynes, J. B. 1939. Undesirable mental sequelae to convulsant drug therapy. J Ment Sci 85: 493–7.
Editor. 1995. News and notes: Anti-ECT legislation in Texas. Convuls Ther 11(2): 148.
Eichhammer, P., Langguth, B., Marienhagen, J., et al. 2003. Neuronavigated repetitive transcranial magnetic stimulation in patients with tinnitus: A short case series. Biol Psychiatry 54(8): 862–5.
Electric shock findings. 1949. Newsweek (Ja 17) 33: 43.
Elizagarate, E., Cortes, J., Gonzalez Pinto, A., et al. 2001. Study of the influence of electroconvulsive therapy on the regional cerebral blood flow by HMPAO-SPECT. J Affect Disord 65: 55–9.
Endler, N. S. 1982. Holiday of darkness, a psychologist's personal journey out of his depression. New York: Wiley.
Enev, M., McNally, K. A., Varghese, G., et al. 2007. Imaging onset and propagation of ECT-induced seizures. Epilepsia 48: 238–44.
Engel, J. Jr. and Pedley, T. A. 2008. Epilepsy: A comprehensive textbook, 2nd edn. Philadelphia: Lippincott Williams & Wilkins.
Engel, J. Jr., Kuhl, D. E., and Phelps, M. E. 1982. Patterns of human local cerebral glucose metabolism during epileptic seizures. Science 218: 64–6.
Eranti, S., et al. 2007. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am J Psychiatry 164(1): 73–81.
Eranti, S., Mogg, A., Pluck, G., et al. 2007. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am J Psychiatry 164: 1.
Erb, A. 1936. Über die Möglichkeiten der kombinierten Insulin-Cardiazolbehandlung der Schizophrenie. Arch Psychiatr 16: 1762–3.
Eschweiler, G. W., Vonthein, R., Bode, R., et al. 2007. Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): A short-term randomised controlled trial in pharmaco-resistant major depression. J Affect Disord 101: 149–57.
Eschweiler, G. W., Wegerer, C., Schlotter, W., et al. 2000. Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychiatry Res 99: 161–72.
Escobar, R., Rios, A., Montoya, I. D., et al. 2000. Clinical and cerebral blood flow changes in catatonic patients treated with ECT. J Psychosom Res 49: 423–9.
Esmaili, T. and Malek, A. 2007. Electroconvulsive therapy in a six-year-old girl suffering from major depressive disorder with catatonic features. Eur J Psychiatry 16: 58–60.
Esquibil, A. J., Krantz, J. C., Truitt, E. B., et al. 1958. Hexafluorodiethyl ether (Indoklon): Its use as a convulsant in psychiatric treatment. J Nerv Ment Dis 126: 530–4.
Fahy, P., Imlah, N., and Harrington, J. 1963. A controlled comparison of electroconvulsive therapy, imipramine, and thiopentone sleep in depression. J Neuropsychiatr 4: 310–14.
Farah, A. and McCall, W. 1993. Electroconvulsive therapy stimulus dosing: A survey of contemporary practices. Convuls Ther 9: 90–4.
Fasanaro, G. 1947. La prognosi nella schizophrenia con le moderne terapie. Acta Neurol 2: 813–20.
Fava, M. and Davidson, K. G. 1996. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 19: 179–200.
Fecteau, S., Pascual-Leone, A., Zald, D. H., et al. 2007. Activation of prefrontal cortex by transcranial direct current stimulation reduces appetite for risk during ambiguous decision making. J Neurosci 27: 6212–8.
Felthous, A. R. 1987. Barclay v. Campbell: Informed consent for antipsychotic medication comes to Texas. Newsl Am Acad Psychiatry Law 12(1): 7–9.
Felthous, A. R. 1989. Legislative update. Newsl Am Acad Psychiatry Law 14(2): 51–3.
Felthous, A. R. 1993. Legislative update. Newsl Am Acad Psychiatry Law 18(3): 69–71.
Fenwick, P. 1998. Does forced normalization exist and how relevant is it to the psychiatrist? In Forced normalization and alternative psychoses of epilepsy (eds. Trimble, M. R. and Scmitz, B.). Petersfield, UK: Wrightson Biomedical. 209–20.
Ferrão, Y. A., Diniz, J. B., Lopes, A. C., et al. 2007. Resistance and refractoriness in obsessive-compulsive disorder [in Portuguese]. Rev Bras Psiquiatr 29 Suppl 2: S66–S76.
Figiel, G. S., Epstein, C., McDonald, W. M., et al. 1998. The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients. J Neuropsychiatry Clin Neurosci 10: 20–5.
Fink, M. 1978. Efficacy and safety of induced seizures (EST) in man. Compr Psychiatry 19: 1–9.
Fink, M. 1979. Convulsive therapy: Theory and practice. New York: Raven.
Fink, M. 1979. Convulsive therapy: Theory and practice. Raven Press New York.
Fink, M. 1984. Meduna and the origins of convulsive therapy. Am J Psychiatry 141: 1034–41.
Fink, M. 1986. Informed ECT for patients and families (with Dr. Max Fink). Lake Bluff, IL: Somatics, LLC.
Fink, M. 1990. How does convulsive therapy work? Neuropsychopharmacology 3: 73–82.
Fink, M. 1990. Is catatonia a primary indication for ECT? J ECT 6: 1–4.
Fink, M. 2000. Electroshock revisited. Am Sci 88: 162–7.
Fink, M. 2001. Convulsive therapy: A review of the first 55 years. J Affect Disord 63: 1–15.
Fink, M. 2002. Stimulus titration and ECT dosing: Move on! J ECT 18: 11–13.
Fink, M. 2003. ‘A Beautiful Mind’ and insulin coma: Social constraints on psychiatric diagnosis and treatment. Harv Rev Psychiatry 11: 284–90.
Fink, M. 2006. The renaissance of ECT. In Elektroconvulsietherapie: Aanbevelingen voor de praktijk (eds. Sienaert, P., De Fruyt, J., and Dierick, M.). Gent: Academia Press.
Fink, M. and Bailine, S. 1998. Electroconvulsive therapy and managed care. Am J Manag Care 4(1): 107–12; quiz 13–14.
Fink, M. and Ottosson, J.-O. 1980. A theory of convulsive therapy in endogenous depression. Significance of hypothalamic functions. Psychiatry Res 2: 49–61.
Fink, M. and Sackeim, H. A. 1996. Convulsive therapy in schizophrenia? Schizophr Bull 22: 27–39.
Fink, M. and Sackeim, H. A. 1998. Theophylline and ECT. J ECT 14(4): 286–90.
Fink, M. and Taylor, M. A. 2007. Electroconvulsive therapy: Evidence and challenges. JAMA 298: 330–2.
Fink, M., Abrams, R., Bailine, S., and Jaffe, R. 1996. Ambulatory electroconvulsive therapy: Report of a task force of the association for convulsive therapy. Association for Convulsive Therapy. Convuls Ther 12(1): 42–55.
Fink, M., Abrams, R., Bailine, S., and Jaffe, R. 1996. Ambulatory electroconvulsive therapy: Report of a task force of the association for convulsive therapy. Association for Convulsive Therapy. Convuls Ther 12: 42–55.
Fink, M., Gujavarty, K., and Greenberg, L. 1987. Serial dexamethasone suppression tests and clinical outcome in ECT. Convulsive Ther 3: 111–20.
Fink, M., Kety, S., McGaugh, J., Williams, T. A., eds. 1974. Psychobiology of convulsive therapy. New York: Wiley.
Fink, M., Rush, A. J., Knapp, R. G., et al. 2007. DSM melancholic features are unreliable predictors of ECT response. A CORE publication. J ECT 23(3): 139–46.
Fink, M., Shaw, R., Gross, C. E., and Coleman, F. S. 1958. Comparative study of chlorpromazine and insulin coma therapy of psychosis. JAMA 166: 1846–50.
Fink, M., Shaw, R., Gross, G. E., et al. 1958. Comparative study of chlorpromazine and insulin coma in therapy of psychosis. JAMA 166: 1846–50.
Finkbeiner, T. EKT-behandlung katatoner Psychosen: Indikation und Praktische durchfuhrung. 1995. In Differnzierung katatoner und neuroleptika-induzierter Bewegungsstorungen (ed. Braunig, P.). Stuttgart/New York: Thieme, pp. 98–104.
Fins, J. J. 2003. From psychosurgery to neuromodulation and palliation: History's lessons for the ethical conduct and regulation of neuropsychiatric research. Neurosurg Clin N Am 14(2): 303–19, ix–x.
Fitzgerald, P. B., Benitez, J., de Castella, A., et al. 2006. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry 163: 88–94.
Fleischmann, A., Sternheim, A., Etgen, A. M., et al. 1996. Transcranial magnetic stimulation downregulates beta-adrenoreceptors in rat cortex. J Neural Transm 103: 1361–6.
Flescher, G. 1941. L'amnesia retrograda dopo l'elettroshock: Contributo allo studio della patogenesi delle amnesie in genere. Schweiz Arch Neurol Psychiatr 48: 1–28.
Folk, J. W., Kellner, C. H., Beale, M. D., et al. 2000. Anesthesia for electroconvulsive therapy: A review. J ECT 16(2): 157–70.
Folkerts, H. 1996. The ictal electroencephalogram as a marker for the efficacy of electroconvulsive therapy. Eur Arch Psychiatry Clin Neurosci 246: 155–64.
Folkerts, H. W., Michael, N., Tolle, R., et al. 1997. Electroconvulsive therapy vs. paroxetine in treatment-resistant depression – a randomized study. Acta Psychiatr Scand 96: 334–42.
Folkerts, H. W., Stadtland, C., and Reker, T. 1998. ECT for organic catatonia due to hereditary cerebellar ataxia. J ECT 14: 53–5.
Folmer, R. L., Carroll, J. R., Rahim, A., et al. 2006. Effects of repetitive transcranial magnetic stimulation (rTMS) on chronic tinnitus. Acta Otolaryngol Suppl (556): 96–101.
Folstein, M. F., Folstein, S. E., and McHugh, P. R. 1975. “Mini-Mental State”: A practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–98.
Folstein, M. R., Folstein, S. E., and McHugh, P. R. 1975. “Mini-Mental State”: A practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–98.
Fontaine, D., Mattei, V., Borg, M., et al. 2004. Effect of subthalamic nucleus stimulation on obsessive-compulsive disorder in a patient with Parkinson disease. Case report. J Neurosurg 100(6): 1084–6.
Ford, P. J. 2007. Neurosurgical implants: Clinical protocol considerations. Camb Q Healthc Ethics 16(3): 308–11.
Forman, M. (Director). 1975. One flew over the cuckoo's nest [Motion picture]. United States: Fantasy Films.
Forman, M. (Director). 1975. One flew over the cuckoo's nest [Motion picture]. United States: Fantasy Films.
Fors, B. M., Isacson, D., Bingefors, K., and Widerlöv, B. 2007. Mortality among persons with schizophrenia in Sweden: An epidemiological study. Nord J Psychiatry 61: 252–9.
Fox, H. A. 2001. Extended continuation and maintenance ECT for long-lasting episodes of major depression. J ECT 17(1): 60–4.
Frame, J. 1990. An autobiography, Vol 2: An angel at my table. London: The Women's Press.
Frankel, F. H.,1973. ECT in Massachusetts: A task force report. Mass Journal Ment Health 3: 3–29.
Fraser, L. M., O'Carroll, R. E., and Ebmeier, K. P. 2008. The effect of electroconvulsive therapy on autobiographical memory: A systematic review. J ECT. 24: 10–17.
Frederikse, M., Petrides, G., and Kellner, C. 2006. Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: A response to the National Institute for Clinical Excellence report. J ECT 22(1): 13–17.
Frederiksen, S. O. and D'Elia, G. 1979. Electroconvulsive therapy in Sweden. Br J Psychiatry 134: 583–7.
Fredman B., d'Etienne, J., Smith, I., et al. 1994. Anesthesia for electroconvulsive therapy: Effects of propofol and methohexital on seizure activity and recovery. Anesth Analg 79: 75–9.
Freeman, C. P. L. 1989. The practical administration of electroconvulsive therapy. ECT Sub-committee of the Royal College of Psychiatrists. London: Gaskell.
Freeman, C. P. L. and Cheshire, K. E. 1986. Attitude studies on electroconvulsive therapy. Convuls Ther 2: 31–42.
Freeman, C. P. L., Basson, J. V., and Crighton, A. 1978. Double-blind controlled trial of electroconvulsive therapy (E.C.T.) and simulated E.C.T. in depressive illness. Lancet 1: 738–40.
Freeman, C. P. L., Hendry, J., and Fergusson, G. 2000. National audit of electroconvulsive therapy (ECT) in Scotland. Final Report. Available at http://www.sean.org.uk/AuditReport/HomePage, accessed November 30, 2007.
Fregni, F., Boggio, P. S., Lima, M. C., et al. 2006a. A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury. Pain 122: 197–209.
Fregni, F., Boggio, P. S., Nitsche, M. A., et al. 2006b. Cognitive effects of repeated sessions of transcranial direct current stimulation in patients with depression. Depress Anxiety 23: 482–4.
Fregni, F., Boggio, P. S., Nitsche, M., et al. 2005a. Anodal transcranial direct current stimulation of prefrontal cortex enhances working memory. Exp Brain Res 166: 23–30.
Fregni, F., Boggio, P. S., Santos, M. C., et al. 2006c. Noninvasive cortical stimulation with transcranial direct current stimulation in Parkinson's disease. Mov Disord 21: 1693–702.
Fregni, F., Freedman, S., and Pascual-Leone, A. 2007. Recent advances in the treatment of chronic pain with non-invasive brain stimulation techniques. Lancet Neurol 6: 188–91.
Fregni, F., Gimenes, R., Valle, A. C., et al. 2006d. A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. Arthritis Rheum 54: 3988–98.
Fregni, F., Liguori, P., Fecteau, S., et al. 2008b. Cortical stimulation of the prefrontal cortex with transcranial DC stimulation reduces smoking cue-provoked craving: A randomized, sham-controlled study. J Clin Psychiatry 69(1): 32–40.
Fregni, F., Marcolin, M. A., Myczkowski, M., et al. 2006. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol 9(6): 641–54.
Fregni, F., Orsati, F., Pedrosa, W., et al. (2008a). Transcranial direct current stimulation of the prefrontal cortex modulates the desire for specific foods. Appetite 51: 34–41.
Fregni, F., Simon, D. K., Wu, A., and Pascual-Leone, A. 2005b. Non-invasive brain stimulation for Parkinson's disease: A systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatry 76: 1614–23.
Fregni, F., Thome-Souza, S., Nitsche, M. A., et al. 2006e. A controlled clinical trial of cathodal DC polarization in patients with refractory epilepsy. Epilepsia 47: 335–42.
Freishtat, H. W. 1985. Electroconvulsive therapy: No ban in Berkeley. J Clin Psychopharmacol 5: 52–3.
Freudenberg, R. 1947. Ten years' experience of insulin therapy in schizophrenia. J Ment Sci 93: 9–22.
Fricchione, G. L., Kaufman, L. D., Gruber, B. L., and Fink, M. 1990. Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia. Am J Med 88: 442–3.
Friedberg, J. 1975. Electroshock therapy: Let's stop shocking the brain. Psychology Today 9(3): 18, 20–21, 23, 25–26.
Friedberg, J. 1976. Shock treatment is not good for your brain. San Francisco: Glide Publications.
Friedberg, J. 1977. Shock treatment, brain damage, and memory loss: A neurological perspective. Am J Psychiatry 134(9): 1010–14.
Friedman, E. and Wilcox, P. H. 1942. Electrostimulated convulsive doses in intact humans by means of unidirectional currents. J Nerv Ment Dis 96: 56–63.
Frostig, J. P. 1940. Clinical observations in insulin treatment of schizophrenia: The symptomology and therapeutic factors of the insulin effect. Am J Psychiatry 96: 1167–90.
Frueh, B. C., Knapp, R. G., Cusack, K. J., et al. 2005. Patients' reports of traumatic or harmful experience within the psychiatric setting. Psychiatr Serv 56: 1123–33.
Frumkin, Ya. P., Slivko, I. M., and Mizrukhin, I. A. 1950. Prolonged intermittent sleep (electrocomatose therapy, electro-narcoshock) in treatment and research of schizophrenia and so-called functional psychical pathology [in Russian]. In Proceedings of the 3rd All-Union Congress of Neuropathologists and Psychiatrists, Moscow, pp. 362–6.
Fu, W., Stool, L. A., White, P. F., and Husain, M. M. 1997. Acute hemodynamic responses to electroconvulsive therapy are not related to the duration of seizure activity. J Clin Anesth 9: 653–7.
Fuchs, T. 2006. Ethical issues in neuroscience. Curr Opin Psychiatry 19: 600–7.
Fuller, S. (Director). 1963. Shock corridor [Motion picture]. United States: Leon Fromkess-Sam Firks Productions.
Fuller, S. (Writer, director, and producer). 1964. Shock treatment [Motion picture]. United States: Arcola Pictures.
Fuster, J. M. 2001. The prefrontal cortex – an update: Time is of the essence. Neuron 30(2): 319–33.
Gabbard, G. O. and Gabbard, K. 1999. Psychiatry and the cinema, 2nd edn. Washington, DC: American Psychiatric Press.
Gabriëls, L., Cosyns, P., Nuttin, B., et al. 2003. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: Psychopathological and neuropsychological outcome in three cases. Acta Psychiatr Scand 107(4): 275–82.
Gabris, G. and Muller, C. 1983. La catatonie dite “pernicieuse.” Encephale 9: 365–85.
Gagné, G. J., Furman, M., Carpenter, L., and Price, L. 2000. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 158: 1933–4.
Gagne, G. G. Jr., Furman, M. J., Carpenter, L. L., and Price, L. H. 2000. Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 157(12): 1960–5.
Galynker, I. I., Weiss, J., Ongseng, F., and Finestone, H. 1997. ECT treatment and cerebral perfusion in catatonia. J Nucl Med 38(2): 251–4.
Gander, D. R., Bennett, P. J., and Kelly, D. H. W. 1967. Hexafluorodiethyl ether (Indoklon) convulsive therapy: A pilot study. Br J Psychiatry 117: 1413–18.
Gangadhar, B. N., Girish, K., Janakiramaiah, N., et al. 1998. Formula method for stimulus setting in bilateral electroconvulsive therapy: Relevance of age. J ECT 14: 259–65.
Gangadhar, B. N., Girish, K., Janakiramiah, N., et al. 1998. Formula method for stimulus setting in bilateral electroconvulsive therapy: Relevance of age. J ECT 14: 259–65.
Gangadhar, B. N., Kapur, R. L., Kalyanasundaram, S. 1982. Comparison of electroconvulsive therapy with imipramine in endogenous depression: A double blind study. Br J Psychiatry 141: 367–71.
Garlow, S. J., Musselman, D. L., and Nemeroff, C. B. 1999. The neurochemistry of mood disorders: Clinical studies. In Neurobiology of mental illness (eds. Charney, D. S., Nestler, E. J., and Bunney, B. S.). New York: Oxford University Press, pp. 348–64.
Gartside, S. E., Ellis, P. M., Sharp, T., and Cowen, P. J. 1992. Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: Effect of repeated antidepressant treatments. Eur J Pharmacol 221: 27–33.
Gastaut, H. and Broughton, R. 1972. Epileptic seizures. Springfield, IL: Thomas.
Gazdag, G., Kocsis, N., and Lipcsey, A. 2004. Rates of electroconvulsive therapy use in Hungary in 2002. J ECT 20: 42–4.
Gazdag, G., Kocsis, N., and Lipcsey, A. 2004. Rates of electroconvulsive therapy use in Hungary in 2002. J ECT 20: 42–4.
Gazdag, G., Kocsis, N., and Lipcsey, A. 2004. Rates of electroconvulsive therapy use in Hungary in 2002. J ECT 20: 42–4.
Gazdag, G., Kocsis-Ficzere, N., and Tolna, J. 2005. Hungarian medical students' knowledge about and attitudes toward electroconvulsive therapy. J ECT 21(2): 96–9.
Gazdag, G., Kocsis-Ficzere, N., and Tolna, J. 2006. The augmentation of clozapine treatment with electroconvulsive therapy. Ideggyogy Sz 59: 261–7.
Gelenberg, A. J. 1976. The catatonic syndrome. Lancet 1: 1339–41.
George, M. S., Nahas, Z., Molloy, M., et al. 2000. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry 48: 962–70.
George, M. S., Rush, A. J., Marangell, L. B., et al. 2005. A one-year comparison of VNS with treatment as usual for treatment-resistant depression. Biol Psychiatry 58: 364–73.
George, M. S., Rush, A. J., Sackeim, H. A., and Marangell, L. B. 2003. Vagus nerve stimulation (VNS): Utility in neuropsychiatric disorders. Int J Neuropsychopharmacol 6: 73–83.
George, M. S., Sackeim, H. A., Rush, A. J., et al. 2000. Vagus nerve stimulation: A new tool for brain research and therapy. Biol Psychiatry 47: 287–95.
George, M. S., Wassermann, E. M., Kimbrell, T. A., et al. 1997. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: A placebo-controlled crossover trial. Am J Psychiatry 154: 1752–6.
George, M. S., Wassermann, E. M., Williams, W. A., et al. 1995. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 6: 1853–6.
George, R., Salinsky, M., Kuzniecky, R., et al. 1994. Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. Epilepsia 35: 637–43.
Georgi, F. and Strauss, R. 1937. Krampfproblem und Insulintherapie: Berücksichtigung klinischer und humoralpathologischer Gesichtpunkte. Schweizer Arch Neurol Psychiatr 39 (supplement): 49–55.
Geretsegger, C. and Rochowanski, E. 1987. Electroconvulsive therapy in acute life-threatening catatonia associated with cardiac and respiratory decompensation. Convuls Ther 3: 291–5.
Geretsegger, C., Nickel, M., Judendorfer, B., et al. 2007. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: A randomized double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. J ECT 23(4): 239–43.
Geretsegger, C., Rochowanski, E., Kartnig, C., and Unterrainer, A. F. 1998. Propofol and methohexital as anesthetic agents for electroconvulsive therapy (ECT): A comparison of seizure-quality measures and vital signs. J ECT 14(1): 28–35.
Gershon, A. A., Dannon, P. N., and Grunhaus, L. 2003. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry 160: 835–45.
Ghaziuddin, N., DeQuardo, J. R., Ghaziuddin, M., et al. 1999. Electroconvulsive treatment in an adolescent treated with craniotomy. J Child Adolesc Psychopharmacol 9: 63–9.
Ghaziuddin, N., King, C. A., Naylor, M. W., et al. 1996. Electroconvulsive treatment in adolescents with pharmacotherapy refractory depression. J Child Adolesc Psychopharmacol 6: 259–71.
Ghaziuddin, N., Laughrin, D., and Giordani, B. 2001. Cognitive side effects of electroconvulsive therapy in adolescents. J Child Adolesc Psychopharmacol 10: 269–76.
Gibbs, F. A., Gibbs, E. L., and Lennox, W. G. 1938. The likeness of the cortical dysrhythmias of schizophrenia and psychomotor epilepsy. Am J Psychiatry 95: 255–69.
Gilabert, E., Rojo, E., and Vallejo, J. 2004. Augmentation of electroconvulsive therapy seizures with sleep deprivation. J ECT 20: 242–7.
Gildenberg, P. L. 2005. Evolution of neuromodulation. Stereotact Funct Neurosurg 83(2–3): 71–9.
Gillespie, J. E. O. N. 1939. Cardiazol convulsions: The subjective aspect. Lancet i: 391–2.
Gilyarovsky, V. A. 1951. Evolution of ideas of I. P. Pavlov in psychiatry [in Russian]. Nevropatologiia i Psikhiatriia 20(1): 17–8.
Gimsa, U., Schreiber, U., Habel, B., et al. 2006. Matching geometry and stimulation parameters of electrodes for deep brain stimulation experiments – numerical considerations. J Neurosci Meth 150: 212–27.
Girish, K. and Gill, N. S. 2003. Electroconvulsive therapy in lorazepam non-responsive catatonia. Indian Journal of Psychiatry 45: 21–5.
Girish, K., Mayur, P., Saravanan, E., et al. 2000. Seizure threshold estimation by formula method: A prospective study in unilateral ECT. J ECT 16: 258–62.
Gitlin, M. C., Jahr, J. S., Margolis, M. A., and McCain, J. 1993. Is mivacurium chloride effective in electroconvulsive therapy? A report of four cases, including a patient with myasthenia gravis. Anesth Analg 77(2): 392–4.
Glassman, A. 1975. Depression, delusions, and drug response. Am J Psychiatry 132: 716–19.
Glassman, A. H., Kantor, S. J., and Shostak, M. 1975. Depression, delusions, and drug response. Am J Psychiatry 132: 716–19.
Glaus, A. 1931. Über Kombinationen von Schizophrenie und Epilepsie. Zeitschrift für die gesamte Neurologie und Psychiatrie 135: 450–500.
Glazer, W. M., Morgenstern, H., and Doucette, J. T. 1993. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications. J Clin Psychiatry 54: 133–9.
Glen, T. and Scott, A. I. F. 1999. Rates of electroconvulsive therapy use in Edinburgh (1992–1997). J Affect Dis 54: 81–5.
Glen, T. and Scott, A.I. F. 2000. Variation in rates of electroconvulsive therapy use among consultant teams in Edinburgh (1993–1996). J Affect Dis 58: 75–8.
Gold, P. W. and Chrousos, G. P. 1985. Clinical studies with corticotropin releasing factor: Implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiency. Psychoneuroendocrinology 10: 401–19.
Goldberg, R. K. and Badger, J. M. 1993. Major depressive disorder in patients with the implantable cardioverter defibrillator: Two cases treated with ECT. Psychosomatics 34(3): 273–7.
Goldenberg, M. A. 1938. Psychopathology of symptomatic (camphor) epilepsy in connection with treatment of schizophrenia with Meduna's method [in Russian]. Sovetskaia Psykhonevrologiia 4: 11–24.
Goldman, D. 1949. Brief stimulus electric shock therapy. J Nerv Ment Dis 110: 36–45.
Goldstein, S. G., Filskov, S. B., Weaver, L. A., and Ives, J. O. 1977. Neuropsychological effects of electroconvulsive therapy. J Clin Psychol 33: 798–806.
Gonda, V. 1941. Treatment of mental disorders with electrically induced convulsions. Dis Nerv Syst 2: 84–92.
Good, R. 1940. Some observations on psychological aspects of Cardiazol therapy. J Ment Sci 86: 491–501.
Goodwin, F. K. and Jamison, K. R. 2007. Manic-depressive illness: Bipolar disorders and recurrent depression. New York: Oxford University Press.
Goswami, U., Kumar, U., and Singh, B. 2003. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: A double blind study. Indian J Psychiatry 45: 26–9.
Gottlieb, J. S. and Huston, P. E. 1951. Treatment of schizophrenia; a comparison of three methods: Brief psychotherapy, insulin coma and electric shock. J Nerv Ment Dis 113: 237–46.
Gray, J. R., Braver, T. S., and Raichle, M. E. 2002. Integration of emotion and cognition in the lateral prefrontal cortex. Proc Natl Acad Sci USA 99(6): 4115–20.
Gray, W. P. and Sundstrom, L. E. 1998. Kainic acid increases the proliferation of granule cell progenitors in the dentate gyrus of the adult rat. Brain Res 790: 52–9.
Greenberg, B. D., George, M. S., Martin, J. D., et al. 1997. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: A preliminary study. Am J Psychiatry 154: 867–9.
Greenberg, B. D., Malone, D. A., Friehs, G. M., et al. 2006. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology 31(11): 2384–93.
Greenblatt, M., Grosser, G. H., and Wechsler, H. 1962. A comparative study of selected antidepressant medications and EST. Am J Psychiatry 119: 144–153.
Greenblatt, M., Grosser, G. H., and Wechsler, H. 1964. Differential response of hospitalized depressed patients to somatic therapy. Am J Psychiatry 120: 935–43.
Gregory, S., Shawcross, C. R., and Gill, D. 1985. The Nottingham ECT study. A double-blind comparison of bilateral, unilateral, and simulated ECT in depressive illness. Br J Psychiatry 146: 520–4.
Greicius, M. D., Krasnow, B., Reiss, A. L., and Menon, V. 2003. Functional connectivity in the resting brain: A network analysis of the default mode hypothesis. Proc Natl Acad Sci USA 100: 253–8.
Grisaru, N., Chudakov, B., Yaroslavsky, Y., and Belmaker, R. H. 1998a. Catatonia treated with transcranial magnetic stimulation. Am J Psychiatry 155: 1626.
Grisaru, N., Chudakov, B., Yaroslavsky, Y., and Belmaker, R. H. 1998b. Transcranial magnetic stimulation in mania: A controlled study. Am J Psychiatry 155: 1608–10.
Grisso, T. and Appelbaum, P. S. 1998. The McArthur Competence Assessment Tool for Treatment (MacCAT-T). Sarasota, FL: Professional Resource Press.
Griswold, R. L. 1958. Plasma adrenaline and noradrenaline in electroshock therapy in man and rats. J Appl Physiol 12: 117–20.
Gross, M., Nakamura, L., Pascual-Leone, A., and Fregni, F. 2007. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand 116: 165–73.
Gross-May, G. 1938. Über epileptiforme Anfälle bei der Insulintherapie der Schizophrenie. Nervenarzt 11: 400–13.
Grosser, G. H., Pearsall, D. J., Fisher, C. L., et al. 1975. The regulation of ECT in Massachusetts: A follow-up. Mass Journal Ment Health 5: 12–25.
Grosser, G., Pearsall, D., and Fisher, C. 1975. The regulation of electroconvulsive therapy treatment in Massachusetts: A follow-up. Mass Ment Health J 5: 12–25.
Grunhaus, L., Dannon, P. N., Schreiber, S., et al. 2000. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: An open study. Biol Psychiatry 47: 314–24.
Grunhaus, L., Pande, A. C., and Haskett, R. F. 1990. Full and abbreviated courses of maintenance electroconvulsive therapy. Convuls Ther 6(2): 130–8.
Grunhaus, L., Schreiber, S., Dolberg, O. T., et al. 2002. Response to ECT in major depression: Are there differences between unipolar and bipolar depression? Bipolar Disord 4(Suppl. 1): 91–3.
Grunhaus, L., Schreiber, S., Dolberg, O. T., et al. 2003. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry 53: 324–31.
Guidelines on convulsive therapy. 1940. [In Russian.] Nevropatologiia i Psikhiatriia 9(3–4): 109–16.
Gunne, L. M. and Andren, P. E. 1993. An animal model for coexisting tardive dyskinesia and tardive parkinsonism: A glutamate hypothesis for tardive dyskinesia. Clin Neuropharmacol 16: 90–5.
Gupta, S., Austin, R., and Devanand, D. P. 1998. Lithium and maintenance electroconvulsive therapy. J ECT 14(4): 241–4.
Gupta, S., Austin, R., Devanand, D. P. 1998. Lithium and maintenance electroconvulsive therapy. J ECT 14: 241–4.
Gurmarnik, S., Young, R., and Alesker, E. 1996. Divided doses of methohexitone improves ECT outcome. Can J Anaesth 43(5 Pt 1): 535.
Guy, W. 1976. ECDEU assessment manual for psychopharmacology. Publication No. 76-338. Washington, DC: Superintendent of Documents, U.S. Government Printing Office, U.S. Dept. of Health, Education, and Welfare.
Gwinn, R. P., Kondratyev, A., and Gale, K. 2002. Time-dependent increase in basic fibroblast growth factor protein in limbic regions following electroshock seizures. Neuroscience 114: 403–9.
Habson, B. 1953. Prognostic factors in electric convulsive therapy. J Neurol Neurosurg Psychiatry 16: 275–81.
Hafner, H. and Kasper, S. 1982. Akute lebensbedrohilche Katatonie: Epidemiologische und klinische Befunde. Nervenzart 53: 385–94.
Hajak, G., Marienhagen, J., Langguth, B., et al. 2004. High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treatment and neuroimaging study. Psychol Med. 34: 1157–63.
Hamilton, M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56–62.
Hamilton, M. 1989. Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry 154: 201–6.
Hapgood, F. 1980. Electroshock: The unkindest therapy of all. Atlantic Monthly 245: 53–6, 58–9.
Harden, C. L., Pulver, M. C., Ravdin, L. D., et al. 2000. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 1: 93–9.
Hardesty, D. E. and Sackeim, H. A. 2007. Deep brain stimulation in movement and psychiatric disorders. Biol Psychiatry 61(7): 831–5.
Harris, J. A. and Robin, A. A. 1960. A controlled trial of phenelzine in depressive reactions. J Ment Sci 106: 1432–7.
Harris, V. 2006. Electroconvulsive therapy: Administrative codes, legislation and professional recommendations. J Am Acad Psychiatry Law 34(3): 406–11.
Harris, V. 2006. Electroconvulsive therapy: Administrative codes, legislation, and professional recommendations. J Am Acad Psychiatry Law 34(3): 406–411.
Harrison, B. E. and Therrien, B. 2007. Effect of antipsychotic medication use on memory in patients with Alzheimer's disease: Assessing the potential risk for accelerated recent autobiographical memory loss. J Gerontol Nurs 33: 11–20.
Harrison, B. E. and Therrien, B. 2007. Effect of antipsychotic medication use on memory in patients with Alzheimer's disease: Assessing the potential risk for accelerated recent autobiographical memory loss. J Gerontol Nurs 33: 11–20.
Harrison, P. J. 2002. The neuropathology of primary mood disorder. Brain 125: 1428–49.
Haskett, R. F., Rosenquist, P. B., McCall, W. V., et al. 2007. The role of antidepressant medications during ECT: New findings from OPT-ECT. J ECT 23: 56.
Hasler, G., Van Der Veen, J. W., Tumonis, T., Meyers, N., et al. 2007. Reduced prefrontal glutamate/glutamine and GABA levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64: 193–200.
Hatta, K., Miyakawa, K., Ota, T., et al. 2007. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. J ECT 23: 233–5.
Hatta, K., Miyakawa, K., Ota, T., et al. 2007. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. J ECT 23: 233–5.
Hatta, K., Miyakawa, K., Ota, T., et al. 2007. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. J ECT 23: 233–5.
Hausmann, A., Kemmler, G., Walpoth, M., et al., 2004a. No benefit derived from repetitive transcranial magnetic stimulation in depression: a prospective, single centre, randomised, double blind, sham controlled “add on” trial. J Neurol Neurosurg Psychiatry 75: 320–2.
Hausmann, A., Kramer-Reinstadler, K., Lechner-Schoner, T., et al. 2004b. Can bilateral prefrontal repetitive transcranial magnetic stimulation (rTMS) induce mania? A case report. J Clin Psychiatry 65(11): 1575–6.
Havaki-Kontaxaki, B, J., Ferentinos, P. P., Kontaxikis, V. P., et al. 2006. Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia. Clin Neuropharmacol 29: 52–6.
Hayman, R. 1991. The death and life of Sylvia Plath. Stroud, UK: Sutton Publishing, pp. 59–87.
Health Ministry of the USSR. 1979. Guidelines on use of electroconvulsive therapy No 21-59/PS59-1/ET [in Russian]. Moscow: Health Ministry of the USSR.
Health Ministry of the USSR. 1989. Use of electroconvulsive therapy in psychiatric practice. Methodical recommendations [in Russian]. Moscow: Administration of Special Medical Aid, Moscow Scientific-Research Institute of Health Ministry of the USSR, 34 pp.
Healy, D. 2002. The creation of psychopharmacology. Cambridge, MA: Harvard University Press, pp. 50–6.
Hebb, D. O. and Penfield, W. 1940. Human behaviour after extensive removal from the frontal lobes. Arch Neurol Psychiatry 44: 421–38.
Heikman, P., Kalska, H., Katila, H., et al. 2002. Right unilateral and bifrontal electroconvulsive therapy in the treatment of depression: a preliminary study. J ECT 18: 26–30.
Heikman, P., Tuunainen, A., and Kuoppasalmi, K. 1999. Value of the initial stimulus dose in right unilateral and bifrontal electroconvulsive therapy. Psychol Med 29: 1417–23.
Hekkenberg, R. J., Irish, J. C., Rotstein, L. E., et al. 1997. Informed consent in head and neck surgery: How much do patients actually remember? J Otolaryngol 26: 155–9.
Helfgott, M. and Gross, T. 1998. Out of tune, David Helfgott and the myth of Shine. Boston: Time Warner Inc.
Hellsten, J., Wennström, M., Mohapel, P., et al. 2002. Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment. Eur J Neurosci 16: 283–90.
Hemphill, R. E. and Walter, W. G. 1941. The treatment of mental disorders by electrically induced convulsions. J Ment Sci 87: 256–75.
Hemphill, R. E. and Walter, W. G. 1941. The treatment of mental disorders by electrically induced convulsions. J Ment Sci 87: 256–75.
Henderson, D. C., Daley T. B., Kunkel, L., et al. 2004. Clozapine and hypertension: A chart review of 82 patients. J Clin Psychiatry 65: 686–9.
Henry, M. E., Schmidt, M. E., Matochik, J. A., et al. 2001. The effects of ECT on brain glucose: A pilot FDG PET study. J ECT 17(1): 33–40.
Henry, M. E., Schmidt, M. E., Matochik, J. A., et al. 2001. The effects of ECT on brain glucose: A pilot FDG PET study. J ECT 17: 33–40.
Henry, T. R., Bakay, R. A., Votaw, J. R., et al. 1998. Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia 39: 983–90.
Hermann, R. C. 1995. Variation in ECT use in the United States. Am J Psychiatry 152: 869–75.
Hermann, R. C., Dorwart, R. A., Hoover, C. W., and Brody, J. 1995. Variation in ECT use in the United States. Am J Psychiatry 152: 869–75.
Hermann, R. C., Dorwatt, R. A., Hoover, C. W., et al. 1995. Variation in ECT use in the United States. Am J Psychiatry 152: 869–75.
Hermann, R. C., Ettner, S. L., Dorwart, R. A., et al. 1998. Characteristics of psychiatrists who perform ECT. Am J Psychiatry 155(7): 889–94.
Hermann, R. C., Ettner, S. L., Dorwart, R. A., et al. 1999. Diagnoses of patients treated with ECT: A comparison of evidence-based standards with reported use. Psychiatr Serv 50: 1059–65.
Hermann, R., Dorwart, R., Hoover, C., and Brody, J. 1995. Variation in ECT use in the United States. Am J Psychiatry 152: 869–75.
Herrington, R. N., Bruce, A., and Johnstone, E. C. 1974. Comparative trial of L-tryptophan and E.C.T. in severe depressive illness. Lancet 2: 731–4.
Herriot, P. M., Cowain, T., and McLeod, D. 1996. Use of vecuronium to prevent suxamethonium-induced myalgia after ECT. Br J Psychiatry 168(5): 653–4.
Heshe, J. and Röder, E. 1976. Electroconvulsive therapy in Denmark. Br J Psychiatry 128: 241–5.
Heshe, J., Roeder, E., and Theilgaard, A. 1978. Unilateral and bilateral ECT. A psychiatric and psychological study of therapeutic effect and side effects. Acta Psychiatr Scand Suppl 275: 1–180.
Heuyer, G., Bour, K. and Leroy, R. 1943. L' électrochoc chez les enfants. Ann Med Psychol (Paris) 2: 402–7.
Hickey, D. R., O'Connor, J. P., and Donati, F. 1987. Comparison of atracurium and succinylcholine for electroconvulsive therapy in a patient with atypical plasma cholinesterase. Can J Anaesth 34(3 Pt 1): 280–3.
Hicks, S. (Director). 1996. Shine [Motion picture]. Australia: Australian Film Finance Corporation.
Hilker, R., Voges, J., Thiel, A., et al. 2002. Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: Measuring the on- and off-conditions with FDG-PET. J Neural Transm 109(10): 1257–64.
Hill, D. 1945. The relationship of electroencephalography to psychiatry. J Ment Sci 91: 281–9.
Himmelhoch, J. M. 1984. Major mood disorders and epileptic changes. In Psychiatric aspects of epilepsy (ed. Blumer, D.). Washington: American Psychiatric Press, pp. 271–91.
Hindmarch, I., Sherwood, N., and Kerr, J. S. 1993. Amnestic effects of triazolam and other hypnotics. Prog Neuropsychopharmacol Biol Psychiatry 17: 407–13.
Hiroi, N., Marek, G. J., Brown, J. R., et al. 1998. Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J Neurosci 18: 6952–62.
Hoch, P. H. 1943. Clinical and biological interrelations between schizophrenia and epilepsy. Am J Psychiatry 99: 507–12.
Hodgson, R. E., Dawson, P., Hold, A. R., et al. 2004. Anaesthesia for electroconvulsive therapy: A comparison of sevoflurane with propofol. Anaesth Intensive Care 32(2): 241–5.
Hoenig, J. and Leibermann, D. M. 1953. The epileptic threshold in schizophrenia. J Neurol Neurosurg Psychiatr 16: 29–34.
Hoffman, R. E., Gueorguieva, R., Hawkins, K. A., et al. 2005. Temporoparietal transcranial magnetic stimulation for auditory hallucinations: Safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry 58: 97–104.
Hoffman, R. E., Hawkins, K. A., Gueorguieva, R., et al. 2003. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry 60: 49–56.
Hoffmann-Richter, U., Alder, B., and Finzen, A. 1998. Electroconvulsive therapy and defibrillation in the paper. An analysis of the media. Nervenarzt 69: 622–8.
Holmberg, G. 1953. The influence of oxygen administration on electrically induced convulsions in man. Acta Psychiatr Neurol Scand 28: 365–86.
Holmberg, G. and Thesleff, S. 1952. Succinyl-choline-iodide as a muscular relaxant in electroshock therapy. Am J Psychiatry 108(11): 842–6.
Holmberg, G. and Thesleff, S. 1952. Succinyl-choline-iodide as a muscular relaxant in electroshock therapy. Am J Psychiatry 108: 842–6.
Holmberg, G. and Thesleff, S. 1952. Succinyl-choline-iodide as a muscular relaxant in electroshock therapy. Am J Psychiatry 108: 842–6.
Holmberg, G., and Thesleff, S. 1952. Succinyl-choline-iodide as a muscular relaxant in electroshock therapy. Am J Psychiatry 108(11): 842–6.
Holsboer, F. 2001. Neuroendocrinology of mood disorders. In Psychopharmacology: The fourth generation of progress (eds. Bloom, F. E. and Kupfer, D. J.). New York: Raven Press, pp. 957–68.
Holtzheimer, P. E. III, Russo, J., Claypoole, K. H., et al. 2004. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation. Depress Anxiety 19(1): 24–30.
Hood, C. (ed.) 2007. ECTAS Newsletter Issue 6, July 2007. Download at http://www.rcpsych.ac.uk/pdf/ECTAS%20July%202007.pdf, accessed September 26, 2008.
Hoppener, R. J. E., Rentmeester, T. H., Arnoldussen, W., et al. 1982. The changes in serum prolactin level following partial and generalized seizures. Br J Clin Pract Suppl 18: 193–5.
Hotchner, A. E. 1966. Papa Hemingway. London: Weidenfeld and Nicholson, pp. 260–99.
Howard, R. (Director). 2001. A beautiful mind [Motion picture]. United States: Universal Pictures.
Hsieh, T. F., Simler, S., Vergnes, M., et al. 1998. BDNF restores the expression of Jun and Fos inducible transcription factors in the rat brain following repetitive electroconvulsive seizures. Exp Neurol 149: 161–74.
Huang, L. Y. 2006. Electroconvulsive therapy in Taiwan: Findings from analysis of the national health insurance database. Annual Meeting of Taiwanese Society of Psychiatry (Oral Presentation #26).
Hubbard, L. R. 1950. Dianetics: The modern science of mental health. Los Angeles: Bridge Publications, Inc.: L. Ron Hubbard Library, 1950, 2000, 2002.
Hubbard, L. R. 1983. Scientology: The fundamentals of thought. Los Angeles: Bridge Publications, Inc.: L. Ron Hubbard Library, 1983, 1988, 1991.
Hubbard, L. R. 1997. Scientology: A new slant on life. Los Angeles: Bridge Publications, Inc.
Hudcova, J. and Schumann, R. 2006. Electroconvulsive therapy complicated by life-threatening hyperkalemia in a catatonic patient. Gen Hosp Psychiatry 28(5): 440–2.
Hughes, T. 1998. The tender place. In Birthday letters. London: Faber & Faber.
Hummel, F., and Cohen, L. G. 2005. Improvement of motor function with noninvasive cortical stimulation in a patient with chronic stroke. Neurorehabil Neural Repair 19: 14–19.
Huppert, F. A., Cabelli, S. T. and Matthews, F. E. 2005. MRC Cognitive Function and Ageing Study. BMC Geriatr 5: 7.
Husain, M. M., McClintock, S. M., Rush, A. J., et al. 2008. The efficacy of acute electroconvulsive therapy in atypical depression. J Clin Psychiatry 69: 406–11.
Husain, M. M., McClintock, S. M., Trevino, K., et al. 2006. Vagus nerve stimulation for treatment-resistant depression. Essent Psychopharmacol 7: 91–7.
Husain, M. M., Rush, A. J., Fink, M. et al. 2004. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): A consortium for research in ECT (CORE) report. J Clin Psychiatry 65: 485–91.
Husain, M. M., Stegman, D., and Trevino, K. 2005. Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: A case report. Ann Gen Psychiatry 4: 16.
Hutchinson, J. and Smedberg, D. 1963. Treatment of depression: A comparative study of ECT and six drugs. Br J Psychiatry 109: 536–8.
Hyrman, V., Palmer, L. H., Cernik, J., and Jetelina, J. 1985. ECT: The search for the perfect stimulus. Biol Psychiatry 20: 634–5.
Imlah, N., Ryan, E., and Harrington, J. 1965. The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacology 1: 38–442.
Impastato, D. J. 1960. The story of the first electro shock treatment. Am J Psychiatry 116: 1113–14.
Inglis, J. 1969. Electrode placement and the effect of E. C. T. on mood and memory in depression. Can Psychiatr Assoc J 14: 463–71.
Inglis, J. 1969. Electrode placement and the effect of ECT on mood and memory in depression. Can Psychiatr Assoc J 14: 463–71.
Inglis, J. 1970. Shock, surgery and cerebral asymmetry. Br J Psychiatry 117: 143–8.
Institute of Medicine Committee on Health Literacy. 2004. Health literacy: A prescription to end confusion. Washington, DC: National Academies Press.
Iodice, A. J. and McCall, W. V. 2003. ECT resistance and early relapse: Two cases of subsequent response to venlafaxine. J ECT 19: 238–41.
Ishihara, K. and Sasa, M. 2001. Potentiation of 5-HT(3) receptor functions in the hippocampal CA1 region of rats following repeated electroconvulsive shock treatments. Neurosci Lett 307: 37–40.
Ishihara, K. and Sasa, M. 2004. Failure of repeated electroconvulsive shock treatment on 5-HT4-receptor-mediated depolarization due to protein kinase A system in young rat hippocampal CA1 neurons. J Pharmacol Sci 95: 329–34.
Iyer, M. B., Mattu, U., Grafman, J., et al. 2005. Safety and cognitive effect of frontal DC brain polarization in healthy individuals. Neurology 64: 872–5.
Jacobsen, J. P. and Mørk, A. 2004. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res 1024: 183–92.
Jaffe, R., Dubin, W., Shoyer, B., et al. 1990. Outpatient electroconvulsive therapy: Efficacy and safety. Convuls Ther 6(3): 231–8.
James, G. W. B., Freudenberg, R., and Cannon, A. T. 1937. Insulin shock treatment of schizophrenia. Lancet i: 1101–4.
Janakiramaiah, N., Gangadhar, B. N., Naga Venkatesha Murthy, P. J., et al. 2000. Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: A randomized comparison with electroconvulsive therapy (ECT) and imipramine. J Affect Disord 57: 255–9.
Janicak, P. G., David, J. M., and Gibbons, R. D. 1985. Efficacy of ECT. A meta-analysis. Am J Psychiatry 132: 297–302.
Janicak, P. G., Davis, J. M., Gibbons, R. D., et al. 1985. Efficacy of ECT: A meta-analysis. Am J Psychiatry 142(3): 297–302.
Janicak, P. G., Dowd, S. M., Martis, B., et al. 2002. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: Preliminary results of a randomized trial. Biol Psychiatry 51: 659–67.
Janis, K., Hess, J., Fabian, J. A., and Gillis, M. 1995. Substitution of mivacurium for succinylcholine for ECT in elderly patients. Can J Anaesth 42(7): 612–13.
Jansen, A. S. P., Nguyen, X. V., Karpitskiy, V., et al. 1995. Central command neurons of the sympathetic nervous system: Basis of the fight-or-flight response. Science 270: 644–6.
Jansen, A. S. P., Nguyen, X. V., Karpitskiy, V., et al. 1995. Central command neurons of the sympathetic nervous system: Basis of the fight-or-flight response. Science 270: 644–6.
Jarrett, R. B., Schaffer, M., McIntire, D., et al. 2000. Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial. Arch Gen Psychiatry 56: 431–7.
Jenusky, S. M. 1992. Public perceptions of electroconvulsive therapy: A historical review. The Jefferson Journal of Psychiatry 10: 2–11.
Jessner, L. and Ryan, V. G. 1941. Shock treatment in psychiatry: A manual. New York: Grune & Stratton.
Jiménez, F., Velasco, F., Salin-Pascual, R., et al. 2005. A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. J Neurosurg 57: 585–93.
Jiménez-Vasquez, P. A., Diaz-Cabiale, Z., Caberlotto, L., et al. 2007. Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression. Eur Neuropsychopharmacol 17: 298–308.
Johnstone E. C., Deakin, J. F. W., Lawler, P., et al. 1980. The Northwick Park electroconvulsive therapy trial. Lancet 2: 1317–20.
Johnstone, E. C. and Deakin, J. F. 1980. The Northwick Park electroconvulsive therapy trial. Lancet 2: 1317–20.
Joseph, K. S., Blais, L., Ernst, P., and Suissa, S. 1996. Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. BMJ 312(7023): 79–82.
Kühn, J., Huff, W., Lee, S.H., Lenartz, D., et al. 2007. Tiefenhirnstimulation bei psychiatrischen Erkrankungen. Fortschritte der Neurologie und Psychiatrie 75: 447–57.
Küppers, E. 1937. Die Insulinbehandlung der Schizophrenie. Dtsch Med Wochenschr 63: 377–84.
Kabbani, N., Negyessy, L., Lin, R., et al. 2002. Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J Neurosci 22(19): 8476–86.
Kadar, A. G., Ing, C. H., White, P. F., et al. 2002. Anesthesia for electroconvulsive therapy in obese patients. Anesth Analg 94(2): 360–1.
Kadar, A. G., Ing, C. H., White, P. F., et al. 2002. Anesthesia for electroconvulsive therapy in obese patients. Anesth Analg 94: 360–1.
Kadar, A. G., Kramer, B. A., Barth, M. C., and White, P. F. 2001. Rapacuronium: An alternative to succinylcholine for electroconvulsive therapy. Anesth Analg 92(5): 1171–2.
Kaestner, F., Mostert, C., Behnken, A., et al. 2007. Therapeutic strategies for catatonia in paraneoplastic encephalitis. World J Biol Psychiatry 12: 1–5 (Epub ahead of print).
Kahlbaum, K. L. 1874. Die Katatonie oder das Spannungsirresein. Eine klinische Form psychischer Krankheit. Berlin: Hischwald.
Kahn, R., Pollack, M., and Fink, M. 1957. Social factors in selection of therapy in a voluntary mental hospital. J Hillside Hosp 6: 216–28.
Kalashnik, Ya. M. 1950. Critical remarks on some scientific works of Serbsky Institute of forensic psychiatry [in Russian]. Nevropatologiia i Psikhiatriia 19(3): 74–5.
Kales, H., Raz, J., Tandon, R., et al. 1997. Relationship of seizure duration to antidepressant efficacy in electroconvulsive therapy. Psychol Med 27: 1373–80.
Kalinowsky, L. B. 1986. History of convulsive therapy. Ann NY Acad Sci 462: 1–4.
Kalinowsky, L. B. and Hippius, H. 1969. Pharmacological, convulsive and other somatic treatments in psychiatry. New York: Grune & Stratton.
Kalinowsky, L. B. and Hoch, P. H. 1961. Somatic treatment in psychiatry. New York: Grune and Stratton.
Kalinowsky, L. B. and Hoch, P. H. 1961. Somatic treatments in psychiatry. New York: Grune & Stratton.
Kalinowsky, L. B. and Worthing H. J. 1943. Results with electric convulsive treatment in 200 cases of schizophrenia. Psychiatr Q 17: 144–53.
Kalinowsky, L. B., Hoch, P. H., and Lewis, N. D. C. 1946. Shock treatments and other somatic procedures in psychiatry. New York: Grune & Stratton.
Kang, I., Miller, L. G., Moises, J., and Bazan, N. G. 1991. GABAA receptor mRNAs are increased after electroconvulsive shock. Psychopharmacol Bull 27: 359–63.
Kantor, S. J. and Glassman, A. H. 1977. Delusional depressions: Natural history and response to treatment. Br J Psychiatry 131: 351–60.
Karliner, W. and Padula, L. J. 1959. Indoklon combined with pentothal and anectine. Am J Psychiatry 116: 358.
Karliner, W. and Savitsky, N. 1952. Office electroshock therapy. J Hillside Hosp 1: 131–44.
Kato, A., Fukazawa, Y., Ozawa, F., et al. 2003. Activation of ERK cascade promotes accumulation of Vesl-1S/Homer-1a immunoreactivity at synapses. Brain Res Mol Brain Res 118: 33–44.
Kaufmann, J. 1999. Shedding light on Shadowland. Available at http://jeffreykauffman.net/francesfarmer/sheddinglight.html.
Kay, D., Fahy, T., and Garside, R. 1970. A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry 117(541): 667–71.
Keck, M. E., Sillaber, I., Ebner, K., et al. 2000. Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain. Eur J Neurosci 12: 3713–20.
Keller, M. B. and Baker, L. A. 1992. The clinical course of panic disorder and depression. J Clin Psychiatry 53 Suppl: 5–8.
Keller, M. B., Lavori, P. W., Mueller, T. I., et al. 1992. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 49(10): 809–16.
Keller, R. 2001. Presenting Rod Keller's alt.religion.scientology week in review 5(40) Jan 21, 2001. Citing article in Atlantic Monthly. http://www.xenu.net/archive/WR/wir-40.html.
Kelley, J. L. 1996. Psychiatric malpractice: Stories of patients, psychiatrists and the law. New Brunswick, NJ: Rutgers University Press, pp. 117–133, p. 129. (For sources for Chapter 9, The Osheroff's Case, Kelley relied on depositions taken in the case, Osheroff v. Chestnut Lodge Hospital, Inc., Claim No. 82-262, Health Claims Arbitration Office, State of Maryland.)
Kellner, C. H. 2001. Towards the modal ECT treatment. J ECT 17: 1–2.
Kellner, C. H., Burns, C. M., Bernstein, H. J., and Monroe, R. R. Jr. 1991. Electrode placement in maintenance electroconvulsive therapy. Convuls Ther 7(1): 61–2.
Kellner, C. H., Burns, C. M., Bernstein, H. J., and Monroe, R. R. Jr. 1991. Electrode placement in maintenance electroconvulsive therapy. Convuls Ther 7: 61–2.
Kellner, C. H., Fink, M., Knapp, R., et al. 2005. Relief of expressed suicidal intent by ECT: A consortium for research in ECT study. Am J Psychiatry 162: 977–82.
Kellner, C. H., Fink, M., Knapp, R., et al. 2005. Relief of expressed suicidal intent by ECT: A consortium for research in ECT study. Am J Psychiatry 162: 977–82.
Kellner, C. H., Knapp, R. G., Petrides, G., et al. 2006. Continuation electroconvulsive therapy versus pharmacotherapy for relapse prevention in major depression: A multi-site study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 63(12): 1337–44.
Kellner, C. H., Knapp, R. G., Petrides, G., et al. 2006. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: A multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 63(12): 1337–44.
Kellner, C. H., Pritchett, J. T., Beale, M. D., and Coffey, E. C. 1997. Handbook of ECT, 1st edn. Washington, DC: Amercan Psychiatric Press, Inc.
Kelly, D. H. W. and Sargant, W. 1965. Present treatment of schizophrenia – a controlled follow-up study. BMJ 1: 147–50.
Kelway, B., Simpson, K. H., Smith, R. J., and Halsall, P. J. 1986. Effects of atropine and glycopyrrolate on cognitive function following anaesthesia and electroconvulsive therapy (ECT). Int Clin Psychopharmacol 1(4): 296–302.
Kennedy, A. 1937. Convulsion therapy in schizophrenia. J Ment Sci 83: 1–20.
Kennedy, S. H., Evans, K. R., Kruger, S., et al. 2001. Changes in regional brain glucose metabolism measured with PET after paroxetine treatment of major depression. Am J Psychiatry 158: 899–905.
Kerbikov, O. V. 1955. Lectures on psychiatry [in Russian]. Moscow: Medgiz, 240 pp.
Kerbikov, O. V., Ozeretsky, N. I., Popov, E. A., and Snezhnevsky, A. V. 1958. Handbook of psychiatry [in Russian]. Moscow: Medgiz, 368 pp.
Kerr, R. A., McGrath, J. J., O'Kearney, R. T., et al. 1982. ECT: misconceptions and attitudes. Aust N Z J Psychiatry 16: 43–9.
Kesey, K. 1962. One flew over the cuckoo's nest. New York: Viking Press.
Kessing, L., LaBianca, J. H., and Bolwig, T. 1994. HIV-induced stupor treated with ECT. Convuls Ther 10: 232–5.
Kety, S. 1974. Effects of repeated electroconvulsive shock on brain catecholamines. In Psychobiology of convulsive therapy (eds. Fink, M., Kety, S., McGaugh, J. W. T. A.). Washington, DC: Winston and Sons.
Kety, S. S. and Schmidt, C. F. 1948. The nitrous oxide method for the quantitative determination of cerebral blood flow in man: Theory, procedure and normal values. J Clin Invest 27: 476–83.
Khalid, N., Atkins, M., and Kirov, G. 2006. The effects of etomidate on seizure duration and electrical stimulus dose in seizure-resistant patients during electroconvulsive therapy. J ECT 22: 184–8.
Khanna, S., Gangadhar, B. N., Sinha, V., et al. 1988. ECT in obsessive-compulsive disorder. Convuls Ther 4: 314–20.
Khedr, E. M., Rothwell, J. C., Ahmed, M. A., and El-Atar, A. 2008. Effect of daily repetitive transcranial magnetic stimulation for treatment of tinnitus: Comparison of different stimulus frequencies. J Neurol Neurosurg Psychiatry 79(2): 212–15.
Kho, K. H., Blansjaar, B. A., De Vries, S., et al. 2004. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia – an open label study. Eur Arch Psychiatry Clin Neurosci 254: 372–9.
Kho, K. H., van Vreeswijk, M. F., Simpson, S., et al. 2003. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT 19(3): 139–47.
Kiloh, L. J., Child, J. P., and Latner, G. 1960. A controlled trial of iproniazid in the treatment of endogenous depression. J Ment Sci 106: 1139–44.
Kimbrell, T. A., Little, J. T., Dunn, R. T., et al. 1999. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry 46: 1603–13.
Kinsey, J. L. 1941. Incidence and cause of death in shock therapy. Arch Neurol Psychiatry 46: 55–8.
Klapheke, M. M. 1997. Electroconvulsive therapy consultation: An update. Convuls Ther 13: 227–41.
Klein, E., Kreinin, I., Chistyakov, A., et al. 1999. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: A double-blind controlled study. Arch Gen Psychiatry 56: 315–20.
Kleinjung, T., Steffens, T., Londero, A., and Langguth, B. 2007. Transcranial magnetic stimulation (TMS) for treatment of chronic tinnitus: Clinical effects. Prog Brain Res 166: 359–67.
Kohn, Y., Freedman, N., Lester, H., et al. 2007. 99mTc-HMPAO SPECT study of cerebral perfusion after treatment with medication and electroconvulsive therapy in major depression. J Nucl Med 48(8): 1273–8.
Kolb, L. and Vogel, V. H. 1942. The use of shock therapy in 305 mental hospitals. Am J Psychiatry 99: 90–100.
Kolbinger, H. M., Höflich, G., Hufnagel, A., et al. 1995. Transcranial magnetic stimulation (TMS) in the treatment of major depression: A pilot study. Hum Psychopharmacol 10: 305–10.
Kole, M. H. P., Fuchs, E., Ziemann, U., et al. 1999. Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats. Brain Res 816: 309–12.
Kondratyev, A., Ved, R., and Gale, K. 2002. The effects of repeated minimal electroconvulsive shock exposure on levels of mRNA encoding fibroblast growth factor-2 and nerve growth factor in limbic regions. Neuroscience 114: 411–16.
Kotresh, S., Girish, K., Janakiramaiah, N., et al. 2004. Effect of ECT stimulus parameters on seizure physiology and outcome. J ECT 20: 10–2.
Kraepelin, E. 1919. Dementia praecox and paraphrenia. Translated by Barclay, R. M. Edinburgh: Livingstone.
Kraepelin, E. 1919. Zur Epilepsiefrage. Zeitschrift ges Neurologie 52: 107–16.
Krahl, S. E., Clark, K. B., Smith, D. C., and Browning, R. A. 1998. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39: 709–14.
Kramer, B. 1985. Use of ECT in California, 1977–1983. Am J Psychiatry 142: 1190–2.
Kramer, B. 1990. ECT use in the public sector: California. Psychiatr Q 61: 97–103.
Kramer, B. 1999. Use of ECT in California, revisited: 1984–1994. J ECT 15: 245–51.
Kramer, B. A. 1985. Use of ECT in California, 1977–1983. Am J Psychiatry 142: 1190–2.
Kramer, B. A. 1990a. Outpatient electroconvulsive therapy: A cost-saving alternative. Hosp Community Psychiatry 41(4): 361–3.
Kramer, B. A. 1990b. Maintenance electroconvulsive therapy in clinical practice. Convuls Ther 6(4): 279–86.
Kramer, B. A. 1993. Anticholinergics and ECT. Convuls Ther 9(4): 293–300.
Kramer, B. A. 1999. A teaching guide for electroconvulsive therapy. Compr Psychiatry 40(5): 327–31.
Kramer, B. A. 1999. Use of ECT in California, revisited: 1984–1994. J ECT 15: 245–51.
Kramer, B. A. 1999a. A naturalistic review of maintenance ECT at a university setting. J ECT 15(4): 262–9.
Kramer, B. A. 1999b. A seasonal schedule for maintenance ECT. J ECT 15(3): 226–31.
Kramer, B. A. and Pi, E.- H. 1990. A survey of ECT use in Asia. Convuls Ther 6: 26–31.
Kramer, B. A., Afrasiabi, A., and Pollock, V. E. 1992. Intravenous versus intramuscular atropine in ECT. Am J Psychiatry 149(9): 1258–60.
Kramer, B. A., Allen, R. E., and Friedman, B. 1986. Atropine and glycopyrrolate as ECT preanesthesia. J Clin Psychiatry 47(4): 199–200.
Krantz, J. C., Traitt J. R., Speers L., and Ling A. S. C. 1957. New pharmacoconvulsive agent. Science 126: 353–4.
Kringelbach, M. L., Jenkinson, N., Owen, S. L., and Aziz, T. Z. 2007. Translational principles of deep brain stimulation. Nat Rev Neurosci 8(8): 623–35.
Krog-Meyer, I., Kirkegaard, C., Kijne, B., et al. 1984. Prediction of relapse with the TRH test and prophylactic amitriptyline in 39 patients with endogenous depression. Am J Psychiatry 141: 945–8.
Krystal, A. D. 1998. The clinical utility of ictal EEG seizure adequacy models. Psychiatr Ann 28: 30–5.
Krystal, A. D., Coffey, C. E., Weiner, R. D., and Holsinger, T. 1998. Changes in seizure threshold over the course of electroconvulsive therapy affect therapeutic response and are detected by ictal EEG ratings. J Neuropsychiatry Clin Neurosci 10(2): 178–86.
Krystal, A. D., Coffey, C. E., Weiner, R. D., et al. 1998. Changes in seizure threshold over the course of electroconvulsive therapy affect therapeutic response and are detected by ictal EEG ratings. J Neuropsychiatry Clin Neurosci 10: 178–86.
Krystal, A. D., Dean, M. D., Weiner, R. D., et al. 2000a. ECT stimulus intensity: Are present ECT devices too limited? Am J Psychiatry 157: 963–7.
Krystal, A. D., Holsinger, T., Weiner, R., et al. 2000b. Prediction of the utility of a switch from unilateral to bilateral ECT in the elderly using treatment 2 ictal EEG indices. J ECT 16: 327–37.
Krystal, A. D., Watts, B. V., Weiner, R. D., et al. 1998. The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient. J ECT 14: 5–14.
Krystal, A. D., Weiner, R. D., and Coffey, C. E. 1995. The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT. J Neuropsychiatry Clin Neurosci 7(3): 295–303.
Krystal, A. D., Weiner, R. D., Coffey, C. E., and McCall, W. V. 1996. Effect of ECT treatment number on the ictal EEG. Psychiatry Res 62(2): 179–89.
Krystal, A. D., Weiner, R. D., Dean, M. D., et al. 2003. Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. J Neuropsychiatry Clin Neurosci 15(1): 27–34.
Krystal, A. D., Weiner, R. D., Lindahl, V., and Massie, R. 2000. The development and retrospective testing of an electroencephalographic seizure quality-based stimulus dosing paradigm with ECT. J ECT 16(4): 338–49.
Krystal, A. D., Weiner, R. D., McCall, W. V., et al. 1993. The effects of ECT stimulus dose and electrode placement on the ictal electroencephalogram: An intraindividual crossover study. Biol Psychiatry 34: 759–67.
Krystal, A. D., Weiner, R., Coffey, C., et al. 1996. Effect of ECT treatment number on the ictal EEG. Psychiatry Res 62: 179–89.
Krystal, A. D., Weiner, R., Lindahl, V. H., et al. 2000c. The development and retrospective testing of an electroencephalographic seizure quality-based stimulus dosing paradigm with ECT. J ECT 16: 338–49.
Krystal, A., Weiner, R., Dean, M., et al. 2003. Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. J Neuropsychiatry Clin Neurosci 15: 27–34.
Kupchik, M., Spivak, B., Mester, R., et al. 2000. Combined electroconvulsive-clozapine therapy. Clin Neuropharmacol 23: 14–16.
Kurita, S. 2007. Future direction of the guideline for electroconvulsive therapy (ECT). Seishin Shinkeigaku Zasshi 109: 348–53 (in Japanese).
Kurland, A. A., Krantz, J. C., and Traitt, E. B. 1960. The treatment of schizophrenia with sustained exposure to hexafluorodiethyl ether. J Nerv Ment Dis 130: 155–9.
Kutcher, S. and Robertson, H. A. 1995. Electroconvulsive therapy in treatment resistant bipolar youth. J Child Adolesc Psychopharmacol 5: 167–75.
Kutcher, S., McDougall, A., and Murphy, A. 2009. Preventing, detecting and managing side effects of medications. In Treating depression in children and adolescents (eds. Rey, J. M. and Birmaher, B.). Baltimore MD: Lippincott Williams & Wilkins, pp. 190–3.
L. Ron Hubbard. http://en.wikipedia.org/wiki/L._Ron_Hubbard, accessed December 22, 2007.
La Rue, A., Spar, J., and Hill, C. D. 1986. Cognitive impairment in late-life depression: Clinical correlates and treatment implications. J Affect Disord 11: 179–84.
Lahutte, B., Cornic, F., Bonnot, O., et al. 2008. Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making. Prog Neuropsychopharm Biol Psychiatry 32: 1393–8.
Lambourn, J. and Gill, D. 1978. A controlled comparison of simulated and real ECT. Br J Psychiatry 133: 514–19.
Lammers, C. H., Diaz, J., Schwartz, J. C., and Sokoloff, P. 2000. Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments. Mol Psychiatry 5: 378–88.
Lamont, S. R., Paulls, A., and Stewart, C. A. 2001. Repeated electroconvulsive stimulation, but not antidepressant drugs, induces mossy fibre sprouting in the rat hippocampus. Brain Res 893: 53–8.
Lamont, S. R., Pauls, A., and Stewart, C. A. 2001. Repeated electroconvulsive stimulation, but not antidepressant drugs, induces mossy fibre sprouting in the rat hippocampus. Brain Res 893: 53–58.
Lancaster, N. P., Steinert, R. R., and Frost, I. 1958. Unilateral electro-convulsive therapy. J Ment Sci 104: 221–7.
Lancaster, N. P., Steinert, R. R., and Frost, I. 1958. Unilateral electro-convulsive therapy. J Ment Sci 104: 221–7.
Lane, R. D., Zeitlin, S. B., Abrams, R., and Swartz, C. M. 1989. Differential effects of right-unilateral and bilateral ECT on heart rate. Am J Psychiatry 146: 1041–3.
Langsley, D. G., Enterline, J. D., and Hickerson, G. X. 1959. A comparison of chlorpromazine and ECT in treatment of acute schizophrenic and manic patients. Arch Neurol Psychiatry 81: 384–91.
Lapensée, M. A. 1992. A review of schizoaffective disorder: II. Somatic treatment. Can J Psychiatry 37: 347–9.
Lapid, M. I., Rummans, T. A., Pankratz, V. S., et al. 2004a. Decisional capacity of depressed elderly to consent to electroconvulsive therapy. J Geriatr Psychiatry Neurol 17: 42–6.
Lapid, M. I., Rummans, T. A., Poole, K. L., et al. 2004b. Decisional capacity of severely depressed patients requiring electroconvulsive therapy. J ECT 19: 67–72.
Lapolla, A., McBurney, R. D., Sutton, C. E., and Nash, L. R. 1965. A clinical report on Indoklon. Dis Nerv Syst 26: 735–8.
Larragoiti, R. J., Valenzuela, E. V., and Machado, R. 1956. Fundamentos y tecnicas de la electroconvulsoterapia modificada. Arch Soc Estud Clin Hab 49: 261–72.
Larsen, M. H., Olesen, M., Woldbye, D. P., et al. 2005. Regulation of activity-regulated cytoskeleton protein (Arc) mRNA after acute and chronic electroconvulsive stimulation in the rat. Brain Res 1064: 161–5.
Larson, G. and Swartz, C. M. 1986. Differences between first and second ECTs given in the same session. Convuls Ther 2: 191–6.
Larson, G., Swartz, C., and Abrams, R. 1984. Duration of ECT-induced tachycardia as a measure of seizure length. Am J Psychiatry 141: 1269–71.
Lauritzen, L., Odgaard, K., Clemmesen, L., et al. 1996. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: A comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 94: 241–51.
Laursen, T. M., Munk-Olsen, T., Nordentoft, M., and Mortensen, P. B. 2007. Increased mortality among patients admitted with major psychiatric disorders: A register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 68: 899–907.
Lauter, H. and Sauer, H. 1987. Electroconvulsive therapy: A German perspective. Convuls Ther 3: 204–9.
Lavelle-Jones, C., Byrne, D. J., Rice, P., and Cuschieri, A. 1993. Factors affecting quality of informed consent. BMJ 306: 885–90.
Lawson, J. S., Inglis, J., Delva N. J., et al. 1990. Electrode placement in ECT: Cognitive effects. Psychol Med 20: 335–44.
Lawson, J. S., Inglis, J., Delva, N. J., et al. 1990. Electrode placement in ECT: Cognitive effects. Psychol Med 20: 335–44.
Lawson, J. S., Inglis, J., Delva, N. J., et al. 1990. Electrode placement in ECT: Cognitive effects. Psychol Med 20: 335–44.
Lebedev, V. A. 1957. Use of home preparation dithylin for facilitation of electroconvulsive therapy and prophylaxis of its complications [in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova 57(12): 1487–93.
Lebensohn, Z. M. 1999. The history of electroconvulsive therapy in the United States and its place in American psychiatry: A personal memoir. Compr Psychiatry 40: 173–81.
Lee, S. H., Kim, W., Chung, Y. C., et al. 2005.A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett 376(3): 177–81.
Lee, S.-H., Kim, W., Chung, Y.-C., et al. 2005. A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett 376: 177–81.
Lerer, B. 1987. Neurochemical and other neurobiological consequences of ECT: Implications for the pathogenesis and treatment of affective disorders. In Psychopharmacology: The third generation of progress (ed. Meltzer, H.). New York: Raven Press.
Lerer, B., Shapira, B., Calev, A., et al. 1995. Antidepressant and cognitive effects of twice-versus three-times-weekly ECT. Am J Psychiatry 152: 564–70.
Lesser, I., Castro, D., Gaynes, B., et al. 2007. Ethnicity/race and outcome in the treatment of depression: Results from STAR*D. Med Care 45: 1043–51.
Lester v.